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Summary 
 
 
 The immune system is vital to ensure the surveillance of organisms against 
pathogens or malignant cells. However, the negative regulation of the immune 
system is equally essential, and defects in the termination of immune signals can 
result in autoimmunity and other pathologies. 
 
 The functioning of the immune system results from the integration of 
signals between and within cells. For some time, studies in immune signaling have 
focused on the molecular events playing a role in activating such cascades. 
However, little was known about how to turn off those signals. Just recently, new 
research started shedding light into mechanisms that ensure the negative 
regulation of immune signaling. 
 The enzyme A20 previously has been shown to be a fundamental 
intracellular negative regulator of immune signals. Mice deficient in the gene that 
codes for the A20 protein, Tnfaip3, have massive generalized inflammation and 
die prematurely. A20 deficient cells fail to terminate TNF and TLR induced 
responses. 
 
 In the first part of this work, we aimed to define the basal signals 
responsible for triggering the spontaneous phenotype of A20-/- mice. While 
genetically removing TNF signals by obtaining A20-/-TNF-/- double-deficient mice 
does not rescue the disease observed in single A20-deficient mice, animals 
lacking the common TLR adaptor protein MyD88 (A20-/-MyD88-/-) have a clear 
amelioration of the A20-/- phenotype, indicating that there are tonic TLR signals 
that need to be constantly terminated by A20. We have shown that these signals 
are likely initiated in the gut, since treatment with broad-spectrum antibiotics that 
reduces commensal intestinal flora also ameliorates disease. Additionally, we 
have demonstrated that A20 also regulates MyD88-independent TLR signals. 
 18 
 
 In the second part of this work, we used a floxed allele of Tnfaip3 to 
generate mice that lack A20 specifically in B-cells. While these mice develop 
normally and show no signs of the general inflammation observed in A20 globally 
deficient mice, Tnfaip3fl/fl and Tnfaip3fl/+ CD19-Cre mice have disrupted lymphoid 
homeostasis and develop lupus-like autoimmunity. A20 deficient B-lymphocytes 
hyper-respond to signals initiated by the BCR, TLRs and CD40. We have 
demonstrated that A20 is necessary to restrict B-cell survival as A20-deficient B-
cells are resistant to Fas-mediated cell death. This provides one mechanism by 
which A20 can prevent B-cell mediated autoimmunity. 
 
 All together, this work bestows several new insights on the mechanisms by 
which A20 plays a central role in maintaining the homeostasis of both the innate 
and the adaptive immune system. We show that there are tonic innate immune 
signals that need to be constantly terminated by A20. Furthermore, we show for 
the first time in vivo that A20 also plays a role in lymphocyte function. These 
findings relate to recent genetic associations between human A20, autoimmune 
diseases and cancer. 
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Sumário 
 
 
 O funcionamento do sistema imunitário é fundamental aos organismos 
desenvolvidos para garantir a prevenção contra microorganismos patogénicos ou 
células malignas. Ainda assim, a regulação negativa do sistema imunitário é 
igualmente essencial, e defeitos na terminação de sinais imunitários podem 
resultar em auto-imunidade e outras patologias. 
 
 O funcionamento do sistema immunitário resulta da integração de sinais 
entre e dentro das células. Na sua fase inicial, a investigação em sinalização 
imunitária dedicou-se principalmente aos processos moleculares responsáveis 
pela activação destas cascatas de sinalização. No entanto, pouco se sabia 
acerca de como terminar estes sinais de activação, de forma a que não se 
prolongassem indefinidamente. Só já mais recentemente, nova investigação 
começou a fornecer pistas acerca dos mecanismos que asseguram a regulação 
negativa da sinalização imunitária. 
 Alguma desta investigação recente demonstrou que a enzima A20 é um 
regulador negativo intracelular de sinais imunitários fundamental. Ratinhos 
deficientes no gene que codifica  a proteína A20, Tnfaip3, desenvolvem níveis 
elevados de inflamação em vários órgãos e morrem prematuramente. Células que 
são deficientes em A20 não possibilitam a terminação de respostas induzidas por 
Tumor Necrosis Factor (TNF) ou Toll-Like-Receptors (TLRs). 
 
 Na primeira parte deste trabalho, o nosso objectivo foi definir quais os 
sinais existentes naturalmente, responsáveis por iniciar o fenótipo espontâneo de 
ratinhos A20-/-. Eliminámos geneticamente sinais mediados por TNF, obtendo 
ratinhos A20-/-TNF-/- e observámos o mesmo nível inflamação registada em 
ratinhos A20-/-. No entanto, animais deficientes na proteína adaptadora comum à 
maioria dos TLRs, MyD88 (A20-/-MyD88-/-), mostraram uma clara diminuição da 
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inflamação comparativamente a A20-/-. Estas observações indicam que há sinais 
inerentes mediados por TLRs que devem ser constantemente terminados através 
da acção de A20. Demonstrámos ainda que a origem mais provável destes sinais 
se encontra no intestino, já que o tratamento com antibióticos de largo espectro, 
que reduz a flora intestinal comensal, resulta num efeito semelhante. 
Demonstrámos ainda que A20 pode também regular sinais de TLRs que não 
dependem de MyD88. 
 
 Na segunda parte deste trabalho, usámos um alelo “floxed” de Tnfaip3 e 
gerámos ratinhos sem A20 única e especificamente em células B. Estes ratinhos 
desenvolvem-se normalmente e não mostram sinais de inflamação generalizada 
como observado em ratinhos globalmente deficientes em A20. Ainda assim, 
ratinhos Tnfaip3fl/fl e Tnfaip3fl/+ CD19-Cre apresentam alterações evidentes na 
homeostase dos seus linfócitos e desenvolvem uma doença com características 
semelhantes a lúpus. Linfócitos B deficientes em A20 respondem 
exageradamente a sinais iniciados pelo B-Cell-Receptor (BCR), TLRs e CD40. 
Demonstrámos que A20 é necessária para restringir a sobrevivência de células B, 
já que células B deficientes em A20 são resistentes à morte celular mediada por 
Fas. Esta descoberta sugere um mecanismo através do qual A20 pode prevenir a 
auto-imunidade mediada por células B. 
 
 Este trabalho fornece novos esclarecimentos sobre os mecanismos 
através dos quais a proteína A20 representa um papel central na manutenção da 
homeostase tanto do sistema imunitário inato como do adaptativo. Demonstrámos 
que há sinais imunitários inatos inerentes que devem ser constantemente 
descontinuados através da acção de A20. Mais ainda, demonstrámos pela 
primeira vez, in vivo, que A20 também têm um papel em linfócitos, o qual está 
relacionado com recentes associações genéticas entre A20 humano, doenças 
auto-imunes e cancro. 
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From Immunity to an Immune System 
 
 Throughout evolution, systems of defense against opportunistic pathogens 
arose in nearly all organisms. Such systems have been crucial for the fitness of 
progressively more complex species. Even though vertebrates continued to evolve 
more sophisticated immune processes, immunity can be found in invertebrates 
and plants, and remarkably, several of the same molecular pathways are shared 
among such different organisms (Howard and Jack, 2007; Litman and Cooper, 
2007). 
 
 Jawed vertebrates as mammals evolved some of the most complex 
immune systems, and humans and mice have been at the center of much of the 
research in the field of Immunology. From the early days of vaccine discovery by 
Edward Jenner and Louis Pasteur, to the recent development of vaccinations and 
treatments against cancer, this research has had wide implications in medicine 
(Janeway, 2005; K. Abbas et al., 2007). 
 Vertebrate immune systems clear pathogenic infections as well as 
recognize and eliminate malignant cells, and as a result immunodeficiency is 
highly deleterious. Nonetheless, exaggerated immune responses can also harm 
the organismʼs own cells and cause equally severe pathologies. Therefore it is 
now extensively recognized that proper functioning of the immune system is 
fundamental and needs to be finely tuned (J. Kindt et al., 2007; Janeway, 2005). 
 
 Plants and invertebrates have several forms of immune defense but are 
jawed vertebrates that have evolved the most complex immune systems. 
Vertebrates like humans and mice have specialized immune cells, and have 
dedicated immune organs that allow the appropriate development of these cells as 
well as their efficient migration through the organism. Immune cells circulate 
through the blood and in dedicated lymphatic vessels, between sites of 
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surveillance and specialized lymphoid organs where they either develop (primary 
lymphoid tissues – bone marrow and thymus) or mount an immune response 
(secondary lymphoid tissues – spleen and lymph nodes). Immunity in vertebrates 
has been classified in two broad types: innate immunity and adaptive immunity 
(Janeway, 2005; K. Abbas et al., 2007). 
 
Evolution of immunity: Innate Immunity and adaptive immunity 
 
 Innate immunity is common to vertebrates, invertebrates and plants. This 
kind of immunity has been characterized by being non-specific, and comprises 
anatomic barriers, physiological barriers, phagocytic and endocytic activities, 
production of anti-microbial proteins, and inflammatory barriers to foreign 
microbes (J. Kindt et al., 2007). Vertebrates like mice and humans also have 
professional innate immune cells (macrophages, neutrophils, dendritic cells (DCs)) 
that develop in the bone marrow and then circulate through the body or reside at 
particular locations. These cells are often the first set of cells to be recruited to a 
site of infection and mediate several of the aforementioned activities (K. Abbas et 
al., 2007).  
 
 The adaptive immune system is found only in jawed vertebrates and is 
characterized by being specific, enabling the development of memory for 
particular pathogens. Lymphocytes serve as the adaptive immune arm, and are 
comprised mainly of T and B cells. Conventional B and T lymphocytes can have 
their DNA somatically rearranged during their development, which allows each cell 
to express a different but specific receptor of its own. Each clone then goes 
through several steps of selection that guarantee its receptor can recognize an 
antigen – a small piece of a certain molecule - that, all working correctly, will 
recognize foreign components (non-self) but not self constituents. When a given 
clone is activated by the presence of its antigen, it rapidly proliferates and 
amplifies the immune response. After an infection is resolved, some of those cells 
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will be maintained as a pool of memory cells, eventually granting a faster and 
stronger secondary response (Janeway, 2005). 
 
 T-lymphocytes recognize antigens through the T cell receptor (TCR). To be 
activated, the TCR needs to bind antigens processed and presented by MHC 
(Major Histocompatibility Complex) molecules in Antigen Presenting cells (APCs) 
as DCs, illustrating the crosstalk between the innate and adaptive immune 
systems. Activated T-cells produce cytokines that aid the clearance of the 
infection (T helper cells) or directly kill infected or transformed cells (Cytotoxic T-
cells), in what has been designated as the Cell-mediated Response (K. Abbas et 
al., 2007). 
 
 B-lymphocytes recognize antigens through the B cell Receptor (BCR) and 
are the cells responsible for producing antibodies (immunoglobulin), mediating the 
so-called Humoral Response. Binding of antibodies to antigenic particles activates 
molecular mechanisms that assist phagocytosis or killing of pathogens by other 
immune cells (Janeway, 2005). 
 
Evolution of theories and models of immunity: from self-non-self 
recognition to the danger model 
 
 Once the existence of an immune system was recognized the central 
question in the field of immunology was (and still is to a certain extent) how does 
the system decide what it reacts to or not? How does it not attack the own 
organism and develop what has later been termed tolerance toward self? Or is it 
ignorance? 
 
 The immunity model that has prevailed the longest, and is still the 
theoretical framework for much of the research, is self-non-self recognition. In 
1959, Frank Macfarlane Burnet suggested the Clonal Selection Theory of 
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Acquired Immunity (Burnet, 1959), in which he proposed that each lymphocyte 
expresses a single surface receptor for a foreign particle and that self-reactive 
lymphocytes are deleted early in development. In 1970, this model was further 
developed by Bretscher and Cohn (Bretscher and Cohn, 1970); after the discovery 
of hypermutation in activated B lymphocytes and thus the renewed chance for 
creation of autoreactive cells, these scientists proposed that there had to be a 
second signal for a cell to initiate a response, and that the second signal was 
coming from an helper cell (later found to be a T-cell). Soon after, Lafferty and 
Cunningham proposed a similar model for T-cell activation, which instead of “help” 
required “costimulation” (Lafferty and Cunningham, 1975). 
 
 For a while it was thought that lymphocytes were responsible for initiating 
the immune response. However, the need for a second signal posed a problem: if 
a second signal (like costimulation) was often not coming from a lymphocyte, and 
thus the adaptive immune harm of the response was not solely responsible for its 
initiation, how was self-reactivity avoided? 
 It is clear that the innate immune system recognizes foreign invaders (non-
self) in a very different manner than cells of the adaptive immune system. 
However, the idea that innate immunity provides “non-specific” protection at 
mucosal barriers is an overly simplistic definition. In 1989, Charles Janeway Jr. 
proposed the revolutionary Pattern Recognition Theory (Janeway, 1989). He 
predicted that innate immunity encompassed the expression of Pattern 
Recognition Receptors (PRRs), which could recognize Pathogen Associated 
Molecular Patterns (PAMPs). Importantly, these PAMPs would consist of patterns 
not found in the host, and thus would be specific to the invading microbe or foreign 
body. PRRs would be responsible for directly sensing pathogens before 
intervention of the adaptive immune system. He called it discrimination between 
infectious non-self and noninfectious self, and evolutionarily this process of 
discriminating foreign bodies in an organism pre-dates the straight self / non-self 
discrimination done by the adaptive immune system (Janeway, 1992). His ideas 
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proved true and provided much of the framework that propelled a large amount of 
the Immunology research in the following decades. The discovery of Toll-Like-
Receptors (TLRs) as the proposed PRRs was the first big step (Medzhitov, 2009). 
 
 Nevertheless, the infectious non-self model still has its limitations. Namely, 
if one thinks about the numerous instances in which there is the need to recognize 
self that might be harmful, like tumours, or the need to be tolerant of non-self that 
might be harmless, like commensals. Matzinger (from discussions with Fuchs) has 
proposed a Danger model (Matzinger, 1994). She adds another layer at the apex 
of the immune response, to include cells and signals from all tissues. Matzingerʼs 
viewpoint is that the immune system does not care as much about non-self 
discrimination as it does need to protect against danger, and that the initiation and 
polarization of an immune response depend on danger signals from the tissue 
affected by any sort of threat (Matzinger, 2002).  
 A number of Danger Associated Molecular Patterns (DAMPs) released by 
injured tissues have now been described. Remarkably, besides identifying new 
receptors, it was found that some PRRs also recognize DAMPs (Matzinger, 2002; 
Rubartelli and Lotze, 2007; Zhang et al., 2010). Furthermore, it has also been 
shown that several cell types in a plethora of tissues can respond to and produce 
cytokines, express PRRs, or have specialized, resident immune cells, contributing 
not only for the initiation but also the polarization of an immune response 
(Janeway, 2005; Matzinger, 2002). Hence, it seems clear that this dialog between 
tissues and the immune system is really happening, and playing a prominent role 
in the overall immune outcome. 
 
Scope of this thesis: what breaks tolerance and do we really need a 
unifying model? 
 
 Nevertheless, is there really a need for a unifying model and de we have to 
decide what matters the most for an immune response? It seems to me that all 
 30 
layers of immune recognition and alert have to be taken into account, with 
absolutely the same level of significance. If at times there have been trends to 
favor this or that aspect of immunity (sometimes just a single cell type), it might as 
well be about time to beware of such biased approaches. The barriers of what the 
immune system is have always been loose, after all. Notwithstanding a few 
defined immune organs, all the same immune cells can travel through numerous 
tissues (with a few exceptions, as the privileged brain) and in those instances it 
becomes harder to define what is the system itself versus what is an immune 
defense process that might as well not immediately involve an immune cell. 
 
 The scope of this work shines some light into just that. Perturbations in a 
single protein, in distinct aspects of the immune system (Toll-like-receptors in 
innate immune cells in chapter 2, B cells in chapter 3) depict how different cells 
and tissues play equally important yet distinct roles in maintaining the 
homeostasis of the immune system. Even if some outcomes do result more 
dramatic, altered intracellular regulation of a number of signals, in distinct cell 
types, appears each time to be sufficient to break immune tolerance at those 
various levels. In fact, conditional gene targeting will probably still be teaching us a 
great amount of new principles about the workings of these complex networks in 
many years to come. And just as selective pressures are diverse, there might as 
well not be a single model of immunity that fits it all. Or at least our knowledge will 
still have to evolve further to be able to create a broad enough theory. Ultimately, 
while interpretations might always be based on the wrong preconceptions, robust 
data might survive the test of time and speak louder than words. 
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Toll-like-receptors 
 
 TLRs are the broadest class of PRRs identified to date, first found in flies, 
and soon established to have an essential role in the immune systems of 
vertebrates like those of humans and mice. In mice and humans, TLRs can be 
expressed in both innate and adaptive immune cells, as well as in non-immune 
cells. However, their highest levels of expression are found in dedicated innate 
immune cells like macrophages, dendritic cells (DCs) or neutrophils (Beutler, 
2009; Kawai and Akira, 2010; Medzhitov, 2009). 
 
 Demonstrating that innate immunity is more specific than previously 
thought, each TLR binds only a few specific ligands of its own. Confirming 
Janewayʼs prediction that PRRs would recognize patterns associated specifically 
with the invading pathogen and not the host itself, TLRs recognize motifs such as 
those of lypopolisacharyde (LPS), found in the wall of Gram negative bacteria 
(TLR4), double stranded RNA, which can be found in viruses (TLR3), or 
methylated DNA, from bacteria (TLR9). There have been 12 TLRs described in 
mice, and 10 in humans. TLRs 1-9 are conserved in both species (Kawai and 
Akira, 2010). Table 1.1 summarizes some basic features of TLRs. 
 
 
Table 1.1 Mouse TLRs, their principal ligands and downstream adaptor proteins. 
Adapted from Beutler, 2009. 
 
TLR Ligands Adaptors
TLR1/2     Glycolipids, Triacyl lipoproteins MyD88,Tirap
TLR2/6     Lipoteichoic acid, Zymosan, Diacyl lipoproteins MyD88, Tirap
polyI:C, dsRNATLR3 TRIF
FlagellinTLR5 MyD88
MyD88ssRNA, imiquimod, loxoribine, otherTLR7
TLR9 MyD88CpG, methylated DNA
ProfilinTLR11 MyD88
?TLR12 ?
?TLR13 ?
TLR4 MyD88,Tirap TRIF,TRAMLPS, Taxol, Heparan, Hyaluronate, F-prot, RSV, G-prot, VSV, Env prot, MMTV, others
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 TLR activation triggers signaling cascades that result in the expression of 
effector genes. Effector genes mediate direct functions in the activated cells, but 
also the expression of surface co-stimulatory molecules and a large number of 
cytokines and chemokines. Many of these are pro-inflammatory cytokines like IL-6 
(Interleukin-6), IL-1β, TNF-α (Tumor Necrosis Factor α) (Beutler, 2009). 
Production of cytokines mediates the amplification and specification of the 
immune response and appropriate clearing of a particular infection. There has 
been ample evidence that innate immune system activation through TLRs is an 
essential component of effective immunity, and is critical for the efficient activation 
of the adaptive immune response (Beutler, 2009; Hou et al., 2008; Kawai and 
Akira, 2010). 
 
Toll-like-receptor signaling 
 
 All TLRs except TLR3 bind the adaptor protein MyD88 (Myeloid 
differentiation primary response gene (88)). Upon TLR engagement, kinases and 
adaptor proteins are recruited by MyD88 and lead to the activation of downstream 
transcription factors. The main transcription factor responsible for the expression 
of pro-inflammatory cytokines downstream of MyD88 is NF-κB (Nuclear factor 
kappa-light-chain-enhancer of activated B cells) (Hayden and Ghosh, 2008). 
 Figure 1.1 summarizes some of the main players in the MyD88-dependent 
pathway of NF-κB activation. 
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Figure 1.1 – TLR signaling through MyD88. 
 
 TRIF (TIR-domain-containing adapter-inducing interferon-β) is an alternate 
TLR adaptor. TLR3 signals exclusively through TRIF, and TLR4 signals through 
both MyD88 and TRIF. The TRIF-dependent pathway also activates NF-κB (and 
thus expression of pro-inflammatory cytokines), but it is best known for activating 
the transcription factor IRF3 (Interferon Regulatory Factor 3). IRF3 is the main 
factor responsible for the expression of type I interferons (IFN) alpha (IFN-α) and 
beta (IFN-β) (Kawai and Akira, 2010). IFNs are critical anti-viral cytokines, and 
thus the TRIF-dependent response is characterized by its anti-viral action. Even 
though IRF3 is the transcription factor leading to the most robust type I IFN 
transcription, IFNs have NF-κB binding sites in their promoters, such that both 
transcription factors can contribute to optimal cytokine production (Sun and Ley, 
2008). There are two distinct pathway branches that activate either NF-κB or 
IRF3. These pathways were defined through the use of knockout cells from 
different TRAFs (TNF receptor associated factors), adaptor proteins downstream 
of TLRs (Häcker et al., 2006; Oganesyan et al., 2006). The pathway branch 
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leading to the activation of NF-κB depends on TRAF6, whereas the one that 
activates IRF3 depends on TRAF3. Figure 1.2 illustrates these findings. 
 
 
Figure 1.2 – TLR signaling through TRIF. 
 
 Nevertheless, this is only a simplified description of the prominent TLR 
signaling pathways, as they occur in innate immune cells (such as macrophages) 
and in response to most foreign agents.  Thus, there are a number of variations in 
these signaling cascades, depending on cell types, ligands, or even cellular 
location of the receptors (Hayden and Ghosh, 2008; Kawai and Akira, 2010). The 
case of the specialized innate immune cells known as plasmacytoid DCs (pDCS, 
as opposed to conventional DCs, cDCs) illustrates this point well. These cells are 
known for being able to produce large amounts of type I interferons in response to 
TLR7 and TLR9 stimulation (Liu and Nussenzweig, 2010; Marshak-Rothstein, 
2006). These are intracellular TLRs that respond to ssRNA and CpG DNA motifs, 
and thus detect viral and bacterial nucleic acids, respectively (Blasius and Beutler, 
2010). Even though these TLRs signal through MyD88, and in other cell types 
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mediate only the production of pro-inflammatory cytokines through NF-κB, in 
pDCs the MyD88-dependent pathway can lead to the production of type I IFNs. It 
is thought this is due to high basal expression of another transcription factor in 
these cells, IRF7, that also transcribes IFNs α and β. IRF7 can be activated by the 
MyD88-dependent pathway. (Häcker et al., 2006; Kawai and Akira, 2010; 
Oganesyan et al., 2006). 
 Additionally, the activation state of the cells can also contribute to the 
differences in their response. For example, it is known that NF-κB can mediate the 
expression of other transcription factors, as IRFs (Hayden and Ghosh, 2008; Sun 
and Ley, 2008). Consequently, a secondary response, after the initial NF-kB 
activation, can vary from a primary one. 
 
Toll-like-receptors in health and disease 
 
 Generation of knockout mice of different TLRs or their common adaptors 
results in impaired responses to pathogens and confirmed their essential role in 
immunity (Beutler, 2009). More recently it has become increasingly evident that 
appropriate TLR mediated responses are also critical in additional facets of the 
health of mice and humans (Kawai and Akira, 2010; Marshak-Rothstein, 2006). It 
was shown that TLR stimulation by commensal flora is essential for gut 
homeostasis (Rakoffnahoum et al., 2004). Furthermore, colonization by particular 
types of commensals can determine the kind of global response initiated by the 
immune system, and whether this is beneficial or harmful to the host (Ivanov et al., 
2009). Finally, failure to regulate TLR responses can lead to chronic inflammation 
and autoimmune disease. In fact, besides the need for modulating the typical 
responses of TLRs to microbes, there has been increasing evidence that some 
TLRs, like intracellular TLRs 7 and 9, can recognize endogenous components, 
such as those of dying cells, and thus contribute to the triggering of a number of 
autoimmune diseases (Krieg and Vollmer, 2007; Marshak-Rothstein, 2006). 
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 In conclusion, TLRs have emerged as fundamental components of the 
innate immune system. It is also recognized that they contribute to the 
orchestration of the whole immune response along with the adaptive immune 
system. Inappropriate TLR responses appear to be related to a number of 
pathologies. Hence, it seems imperative to understand the regulation of TLR 
signals. 
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B cells 
 
 B cells first develop in the bone marrow, from which they emigrate as 
immature B cells. They conclude most of their differentiation to mature B cells in 
the spleen, after which they can circulate in the blood stream or through other 
peripheral lymphoid organs (Allman and Pillai, 2008). 
 Figure 1.3 schematizes the life of a B cell. 
 
 
Figure 1.3 – Development and differentiation of B cells from the bone marrow to 
the periphery. Adapted from Dörner, 2009. 
 
 The antigen recognition component of the BCR is membrane-bound 
immunoglobulin (Ig). Two designated heavy chains and two light chains constitute 
immunoglobulin protein. Once a B-cell is activated, its ultimate goal is to generate 
and secrete large amounts of antigen-specific immunoglobulin. There are several 
isotypes of Ig, and the primary humoral response is initially characterized by IgM 
secretion. After encountering their antigen and becoming activated, B cells can 
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undergo a process called class-switch recombination: the Ig chains expressed are 
changed in order to produce other antibody isotypes, such as IgGs, IgA or IgD, 
each with particular characteristics appropriate for the type of response required 
(Goodnow et al., 2010; Janeway, 2005).  
 
 Immunoglobulin, including the BCR, binds unprocessed antigen, meaning 
that on the contrary of T lymphocytes, B cells do not recognize processed 
peptides presented by MHC molecules. Instead, they bind intact antigen, which 
they can access directly or extract from innate immune cells (Cyster, 2010; Qi et 
al., 2006). B cells can function as APCs themselves by expression of MHC class II 
molecules (K. Abbas et al., 2007). 
 
 Besides producing antibodies, B cells also produce cytokines and interact 
with other immune cells, contributing to the intricate conduction of the immune 
response. In fact, B lymphocytes express a diverse repertoire of different 
receptors besides the BCR, such as TLRs and TNFR family receptors, like CD40 
and BAFFR (B-call Activating Factor Receptor). B cells integrate all these different 
stimuli in an effort to mount the most appropriate immunological outcome for the 
host (Dörner and Lipsky, 2006; Sen, 2006).  
 
B cell selection 
 
 Like T cells, B cells go through steps of selection during their development 
that ensure their receptor binds a foreign element (positive selection) but not a 
self-antigen (negative selection). B cells are selected at several stages of 
development, allowing the diversification of checkpoints and decreasing the 
likelihood of failure (Goodnow et al., 2010; Shlomchik, 2008). The two main 
checkpoints of negative selection happen in the bone marrow and in structures 
called germinal centers (GCs), present in the spleen and lymph nodes. Both in the 
bone marrow (central tolerance) and in GCs (peripheral tolerance), negative 
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selection of autoreactive B cells can happen via three main mechanisms: clonal 
deletion (death of the autoreactive cell), anergy (the cell is turned unresponsive) or 
a process called receptor editing, in which the light chain of the BCR (at first κ) is 
replaced by an alternative one (type λ) by DNA rearrangement (Shlomchik, 2008; 
von Boehmer and Melchers, 2010; Yurasov and Nussenzweig, 2007). 
 
 It is accepted that selection takes in at least one basic principle: one signal 
alone is not enough to base an appropriate fate decision. The simplest version of 
this theory was first described as a two signal model, but today we understand 
that it might be more than a binary mechanism (Bretscher and Cohn, 1970; 
Goodnow et al., 2010; von Boehmer and Melchers, 2010). Regardless, itʼs 
probably safe to say that there should always be at least 2 signals, if not more, for 
a B cell to survive and be “given permission” to proliferate when encountering its 
antigen. Accordingly, much of this selection will involve growth versus death 
decisions (Shlomchik, 2009). 
 
 The first selection signal is usually from the BCR, and binding of antigen. 
To ensure that the B cell generates a productive BCR that recognizes an antigen 
(positive selection), weak BCR stimulation or no stimulation at all lead to B cell 
anergy or death, respectively. In fact, B cells die easily without any stimulation, in 
what can be designated as “death by neglect” (Sen, 2006). Nevertheless, 
excessively strong BCR stimulation without any other signal also leads to B cell 
death, likely ensuring the avoidance of what can be the signal of an abundant self-
antigen (Dörner and Lipsky, 2006). Hence, strength of signal is also decisive. The 
second stimulus is usually co-stimulatory, and promotes B cell survival and even 
proliferation; it can be TLR stimulation, from antigenic moieties that most likely 
belongs to a pathogen, or TNFR family stimulation, like BAFFR in the bone 
marrow or CD40 in GCs (Shlomchik, 2009). 
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 Autoreactive B cells can also be killed through direct stimulation of their 
death receptors. The most notable case is that of Fas (also known as CD95), 
which is expressed in B and T cells (Shlomchik, 2008). Fas deficient mice, and 
more strikingly, mice that lack Fas specifically on GC B cells, have profound 
autoimmunity, characterized by expansion of B an T cells and production of self-
reactive antibodies (Hao et al., 2008; Rathmell et al., 1995).  Activated T cells can 
also express FasL, and just as they give a survival and growth signal to B cells 
through CD40L, they will provide a death signal instead. Curiously, still, it was also 
observed that an activated B cell expressing B7.2 (also known as CD86) can bias 
a T cell to actually give a weak survival signal through FasL (Rathmell et al., 
1998). 
 
Germinal Centers 
 
 There is an extensive cross talk between B and T cells that modulates both 
sides of a response, i.e., the humoral and cell mediated arms of adaptive immunity 
(Dörner and Lipsky, 2006). The privileged meeting point for lymphocytes is 
generally in GCs, where B cells and T cells, along with a network of DCs (follicular 
DCs) are in tight communication. These structures enhance the likelihood of 
exposure to antigens (Goodnow et al., 2010). 
 
 After leaving the bone marrow (and thus having already passed central 
tolerance selection), naïve B cells will traffic until they are exposed to antigen and 
first get activated. An activated B cell can differentiate into either a plasma cell, a 
GC B cell or a memory B cell. Plasma cells are characterized by making large 
amounts of antibodies and memory B cells for being long lived. GC B cells divide 
rapidly and can themselves become memory cells or plasma cells. Even though 
we understand that these decisions also depend on the integration of several 
signals, the outcome cannot be easily predicted (Goodnow et al., 2010; 
Shlomchik, 2008). 
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 In GCs, B cells divide rapidly, and this rate of division leads to expression 
of enzymes that allow both Class Switch Recombination and Somatic 
Hypermutation. Somatic hypermutation results in changes of about one nucleotide 
per cell division in the Ig complimentary determining regions of the B cell DNA. 
This nucleotide change results in either a silent mutation, where the same amino 
acid is encoded, or a replacement mutation, where a different amino acid is 
encoded. Ultimately the cell expresses a different amino acid and an altered BCR 
in the regions that determine antigen recognition. This can result in higher, lower 
or even inexistent affinity for the antigen that was bound by the BCR in the first 
place. High affinity clones are likely selected to survive and enriched in the 
resulting clonal population, whereas low affinity ones most likely die through an 
inability to compete for antigen and survival signals. This process is called Affinity 
Maturation (Yurasov et al., 2005). 
 
 During somatic hyper-mutation, however, some of these matured receptors 
can bind self-antigen creating another chance of escape of autoreactive cells. 
Therefore, there is the renewed need for negative selection. Once more, the 
outcome depends on the integration of several signals, to which the B cells are 
exposed during their stay at the GC. BCR strength is integrated with any TLR 
signals and the extensive crosstalk with the T cells. Besides expressing MHCII, 
activated B cells may also often express B7.1 (CD80), B7.2 (CD86), and ICOS-L 
(Inducible T cell Costimulator – Ligand), which are ligands for CD28, CTLA4 
(Cytotoxic T-Lymphocyte Antigen 4), or ICOS on T cells, and act as co-
stimulators. In turn, activated T cells will express CD40-L, Fas-L, and secrete IL-4. 
It is recognized that all of these factors play critical roles in the selection process. 
Still, mathematical modeling would probably be needed to try to predict the result 
of the integration of all the different signal combinations and their different 
intensities (Dörner and Lipsky, 2006; Goodnow et al., 2010; Rathmell et al., 1996; 
Shlomchik, 2009). 
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 Figure 1.4 depicts some of these interactions. 
 
 
Figure 1.4 – B – T – myeloid cell interactions at Germinal Centers 
 
B cells in autoimmunity and cancer 
 
 Failure to appropriately regulate each one of the processes described 
above can result in impaired selection, escape of autoreactive cells and ultimately 
systemic autoimmune disease. In fact, it is well documented that conditions of B 
cell mediated autoimmune disease as Systemic Lupus Erythematosus (SLE) are 
the consequence of defects in B cell selection, which result in a profound “break of 
tolerance” to self (Cappione et al., 2005; Fairhurst et al., 2006; Yurasov et al., 
2005). 
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 Besides the intricate control network required for maintaining tolerance, 
regulation of B cell function is also necessary to avoid cancer. B cell lymphomas 
are the result of uncontrolled expansion of a certain B cell population, and often 
show deregulated B cell activity (Küppers, 2009).  
 
 BCR stimulation leads to MAPK (Mitogen-activated protein kinases) and 
NF-kB activation. Similarly, TLRs, CD40 and the BAFFR also activate NF-κB. We 
could then hypothesize that much of the signal integration that mediates selection 
decisions and proper functioning of B cells depends on NF-kB signals strength 
and its regulation (Sen, 2006). 
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The transcription factor NF-κB 
 
 NF-κB was first indentified as a regulator of the kappa light chain of B cells. 
Soon it was discovered it functioned as the central transcription factor downstream 
of a diverse number of immune signaling networks. Over the past two decades, 
increasingly more functions of NF-kB have been described, many in immune 
related functions but some also in additional settings. Furthermore, the activation 
of NF-kB has turned into an excellence model of inducible gene expression, which 
principles of functioning go beyond the immune system (Hayden and Ghosh, 
2008). 
 
 There are 5 different forms of NF-κB: p65 (RelA), p50 (NF-κB1), p52 (NF-
κB2), cRel and RelB. All of these forms have in common a Rel homology domain 
(RHD) that accounts for DNA binding and homo- and heterodimerization, 
necessary for transcriptional activity. Inducible gene expression is achieved given 
that NF-κB is found in inactive states prior to a stimulating signal (Hayden and 
Ghosh, 2008). 
 
 In the predominant canonical pathway, IκBα (Inhibitor of NF-κB) binds 
p50/RelA dimers in the cytoplasm, keeping them from travelling to the nucleus and 
initiating transcription. Active IKKs (IκB kinases) mediate the phosphorylation and 
consequent degradation of IκBα, which allows initiation of transcription by NF-κB 
dimers. In the non-canonical pathways, instead of IκB proteins, unprocessed 
forms of NF-κB keep dimers inactive. In B cells, downstream of CD40, the 
BAFFR, or TNFRII, IKKα phosphorylates p100, resulting in its proteolysis into the 
active form p52 and release of p52/RelB dimers (Hayden and Ghosh, 2008; Sun 
and Ley, 2008). 
 
 The families of receptors discussed so far – TLRs, BCR, TNFR family 
receptors – all result in downstream induction of NF-κB activity, even receptor also 
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activates some additional transcription factors or other downstream responses of 
their own. Every one of these NF-κB activation pathways has its particular version 
of signaling intermediates, and in a given cell type results in the expression of a 
specific transcriptional program by NF-κB. Nonetheless, such routes seem to work 
by combining some of the same modules that in the end results in IKK activation 
(Kawai and Akira, 2010; Sen, 2006; Sun and Ley, 2008). 
 
Regulation of NF-κB through ubiquitylation 
 
 While the first decade of research after the identification of NF-κB quickly 
provided a lot of knowledge about its activation mechanisms, less was understood 
about how to turn off these signals. Thus there remained a gap in our 
understanding in the regulation of inflammatory activity. Still today not much is 
known about what happens to stop NF-κB at the transcription level. But, in this 
past decade there has been remarkable progress on understanding the regulation 
of upstream cascades that signal to activate IKKs (Hayden and Ghosh, 2008; Sun 
and Ley, 2008). 
 
 Ubiquitylation is the post-translation addition of one or more (chains) 
ubiquitin molecules to proteins. Ubiquitin is a 76 amino acid protein that can be 
covalently affixed to other proteins. It requires E1 (activating), E2 (conjugating) 
and E3 (ligase) enzymes, as illustrated in Figure 1.5. Ubiquitylation was first 
identified as the addition of chains of ubiquitin with covalent bounds between 
lysines at position 48. These so-called K48 chains normally target proteins for 
degradation. However, it was found that mono-ubiquitylation and other types of 
ubiquitin chains can mediate various non-degrative functions. The most notable 
non-degrative ubiquitin chain type is K63 ubiquitin, which is necessary for diverse 
protein-protein interactions or protein activation (Sun, 2008)  
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Figure 1.5 – Protein ubiquitylation. Sun, 2008. 
 
 More recently, ubiquitylation events have been identified in a number of 
signaling intermediates that lead to NF-kB activation. Notably, IKKγ is K63 
ubiquitylated, as well as a number of TRAF molecules, namely TRAF6. Alongside 
with these discoveries, several proteins were described as negative regulators of 
immune signals. Some of the most significant NF-kB signaling regulators turned 
out to be ubiquitin-editing-enzymes, that can either remove ubiquitin chains 
(deubiquitylating enzymes, or DUBs) or mediate ubiquitin addition as E3 ligases. 
Importantly, a remarkable enzyme, A20, can perform both functions (Coornaert et 
al., 2009; Sun and Ley, 2008). 
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The ubiquitin editing enzyme A20 
 
 The A20 protein is encoded by the Tnfaip3 gene. It was identified 20 years 
ago as an NF-κB inducible gene downstream of TNFα and initial observations 
suggested it could be part of a regulatory negative feedback mechanism (Krikos et 
al., 1992; Opipari et al., 1990). The generation of A20 knockout mice confirmed its 
fundamental role in terminating NF-κB signals. A20-/- mice present with multi-
organ spontaneous inflammation and cachexia and die prematurely by 3-4 weeks 
of age. A20 deficient mouse fibroblasts (MEFs) and thymocytes are 
hyperresponsive to TNFα, showing prolonged NF-κB activation and TNF-induced 
apoptosis (Lee et al., 2000).  
 
 
Figure 1.6 – Failure to terminate TNF-induced NF-κB and cell death responses in 
A20 deficient mice. 
 
 Analysis of the A20 sequence identified an N-terminal OTU (Ovarian 
Tumor) cysteíne protease domain and seven C-terminal Zinc Fingers. Further 
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research demonstrated that A20 is a dual function ubiquitin-modifying enzyme: It 
can remove K63 ubiquitin chains from RIP-1 (Receptor Interacting Protein 1), 
which needs them to operate as an essential mediator of TNFR induced NF-κB 
activity; Additionally, A20 can also use its zinc fingers to act as an E3 ligase and 
add K48 ubiquitin chains to RIP-1, targeting it for degradation (Wertz et al., 2004). 
 
 The latter observations uncovered a novel mechanism by which signals can 
be terminated through regulation of different ubiquitylation events. Nonetheless, 
there is still a lot to be understood about the many potential functions of this 
enzyme. Namely, it is remains unclear if there is ubiquitin type specificity for each 
one of A20ʼs domains, whether that depends on each particular target, and finally, 
whether additional targets exist but remain unidentified. Furthermore, very 
recently, an additional mechanism for A20ʼs action has been proposed, with 
evidence showing that A20 could antagonize TRAF E3 ligase activities by 
impeding them from binding E2 ligases (Shembade et al., 2010). 
 
 In spite of A20 being a potent inhibitor of TNF induced signals, A20-/-TNF-/- 
mice also displayed spontaneous multi-organ inflammation and early lethality as 
A20-/- mice (Boone et al., 2004). This indicates signals other than TNF are 
responsible for initiating the spontaneous inflammation in the absence of A20. 
RAG (Recombination Activation Genes) deficiency (results in the absence of T an 
B cells) also does not rescue the A20-/- mice phenotype, demonstrating that B and 
T lymphocytes also are not responsible for initiating the generalized inflammation 
in these animals. On the other hand, A20 was shown to be required to terminate 
TLR and NOD (Nucleotide-binding oligomerization domain-containing) protein 
signals, and promote deubiquitylation of TRAF6 and RIP2, respectively (Boone et 
al., 2004; Hitotsumatsu et al., 2008). 
 
 More recently, some hints into the regulation of A20 itself have been 
discovered. Firstly, A20 binding proteins and some of their roles in collaborating 
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with A20 on signaling regulation have been described (Iha et al., 2008; Oshima et 
al., 2009; Papoutsopoulou et al., 2006; Shembade et al., 2007; Shembade et al., 
2009; Wullaert et al., 2006). Secondly, post-translational modifications of A20 
were also shown to have a role in signaling regulation. Downstream of TNF and 
LPS, IKKβ phosphorylates A20, which increases its inhibitory potential by and 
unknown mechanism (Hutti et al., 2007); In T an B cells, MALT1 can cleave A20 
and disrupt its inhibitory activity (Coornaert et al., 2008). 
 
A20 in autoimmunity and cancer 
 
 In the past 2 years there has been a striking number of reports of genetic 
associations between TNFAIP3 polymorphisms and human autoimmune 
diseases: Inflammatory Bowel Disease (IBD), Systemic Lupus Erythematosus 
(SLE), Rheumatoid Arthritis (RA), Type I Diabetes (T1D), Coeliac Disease and 
Atherosclerosis (Bates et al., 2009; Duan et al., 2009; Graham et al., 2008; 
Kawasaki et al., 2010; Musone et al., 2008; Orozco et al., 2009; Plenge et al., 
2007; Prahalad et al., 2009; Thomson et al., 2007; Trynka et al., 2009). 
Additionally, somatic mutations and deletions of A20 were found in various B cell 
lymphomas at remarkably high frequencies (Compagno et al., 2009; Honma et al., 
2007; Honma et al., 2009; Kato et al., 2009; Malynn and Ma, 2009; Novak et al., 
2009; Schmitz et al., 2009). 
 
 In conclusion, A20 has emerged as a fundamental regulator of immune 
signals. Its magnitude and versatility, suggest there is still a lot to be learned about 
its further roles in different cell types and pathways, and the variations of 
mechanism it uses to accomplish its tasks. Additionally, the recent associations 
with a large number of human diseases confirm its absolute importance. 
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THESIS AIMS AND RATIONALE  
 
 In the first part of this thesis work, described in chapter 2, we aimed to 
define which basal in vivo signals are responsible for initiating the systemic 
inflammation in the absence of A20. While TNF signals were excluded from 
accounting for triggering the multi-organ disease, it was found that A20 terminates 
TLR responses. Given that TLRs are essential and proximal regulators early 
during immune responses, and thus could trigger a widespread activation of the 
immune system, we asked whether TLR signals had to be constantly regulated by 
A20 in homeostatic conditions (i.e. without further external stimulation). Moreover, 
given that there is permanent TLR stimulation in the gut, we hypothesized this 
could be the site of initiation of such signals. 
 
 In chapter 3, our goal was to identify additional roles for A20 in the adaptive 
immune system. Precisely, we asked whether A20 regulates B cell function. 
Whereas in most cell types A20 expression is low before stimulation dependent 
induction, in B and T cells the baseline expression of A20 is higher, suggesting it 
could have a role in lymphocytes. Moreover, B cells are regulated by signals that 
lead to activation of NF-κB and which share some of the same intermediate 
molecules participating in A20 targeted pathways. Finally, the GWAS (Genome 
Wide Association Studies) that linked A20 with B cell mediated autoimmune 
disease (SLE) and the frequent somatic deletions and mutations of A20 in B cell 
lymphomas, further indicate a role for A20 in B lymphocytes. 
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CHAPTER 2 
 
 
 
 
Homeostatic MyD88-dependent signals cause 
lethal inflammation in the absence of A20 
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SUMMARY 
 
 
 Toll-like receptors (TLRs) on host cells are chronically engaged by 
microbial ligands during homeostatic conditions. These signals do not cause 
inflammatory immune responses in unperturbed mice, even though they drive 
innate and adaptive immune responses when combating microbial infections. A20 
is a ubiquitin-modifying enzyme that restricts exogenous TLR-induced signals. We 
show that MyD88-dependent TLR signals drive the spontaneous T cell and 
myeloid cell activation, cachexia, and premature lethality seen in A20-deficient 
mice. We have used broad spectrum antibiotics to demonstrate that these 
constitutive TLR signals are driven by commensal intestinal flora. A20 restricts 
TLR signals by restricting ubiquitylation of the E3 ligase tumor necrosis factor 
receptor – associated factor 6. These results reveal both the severe 
proinflammatory pathophysiology that can arise from homeostatic TLR signals as 
well as the critical role of A20 in restricting these signals in vivo. In addition, A20 
restricts MyD88-independent TLR signals by inhibiting Toll/ interleukin 1 receptor 
domain – containing adaptor inducing interferon (IFN) β – dependent nuclear 
factor KB signals but not IFN response factor 3 signaling. These findings provide 
novel insights into how physiological TLR signals are regulated.  
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Abbreviations used: BMDM, bone marrow – derived macrophage; HSC, 
hematopoietic stem cell; IRAK-M, IL-1R – associated kinase M; IRF, IFN response 
factor; MCP, monocyte chemoattractant protein; mRNA, messenger RNA; PAMP, 
pathogen-associated molecular pattern; poly (I:C), poly-inosine:cytosine; RIP, 
receptor-interacting protein; R.U., relative units; SIGIRR, single Ig and TIR 
domain; SOCS, suppressor of cytokine signaling; TIR, Toll/ IL-1 receptor; TLR, 
Toll-like receptor; TRAF, TNF receptor – associated factor; TRIF, TIR domain – 
containing adaptor inducing IFN-β.  
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INTRODUCTION 
 
 
 Higher eukaryotes are colonized by microbial organisms, predominantly on 
interfaces with the environment such as the skin and gastrointestinal tract (1). 
Recent studies suggest that host cells, including professional antigen-presenting 
cells, “ sense ” the presence of microbial molecules under homeostatic conditions 
(2, 3). This sensing is performed by several families of cellular receptors, including 
Toll-like receptors (TLRs) and non-TLR proteins such as NOD/CATERPILLAR 
family proteins (4, 5). Collectively, these proteins are thought to bind to conserved 
pathogen-associated molecular patterns (PAMPs) and activate proinflammatory 
signals in host cells. The appreciation that microbial sensors such as TLRs may 
chronically or tonically engage PAMPs during homeostasis raises a major 
question: if TLRs trigger both adaptive and innate immune responses, why do 
homeostatic TLR signals not trigger inflammation? Despite the presence of up to 
1011 bacteria per gram of luminal contents within the gastrointestinal tract, most 
humans tolerate this colonization without adverse effects. Indeed, host cell 
sensing of luminal microbes may provide beneficial signals under homeostatic 
conditions (2). How immune responses to commensal flora are restrained during 
homeostasis thus remains one of the central questions in immune regulation.  
 
 Inflammatory TLR signals might be distinguished from homeostatic TLR 
signals by the quantity or strength of TLR signals, by cell type – specific 
responses, by the cellular location of PAMP/TLR interactions (e.g., apical vs. 
basal surfaces or intracellular vs. membrane-bound receptors), or by additional 
extracellular cues (e.g., cellular stress response proteins) that modify the cellular 
interpretation of such signals. Among these general mechanisms, perhaps the 
most attention has been focused on proteins that regulate the intracellular 
strength, duration, and/or character of PAMP-triggered signaling.  
 
 TLR proteins contain leucine-rich repeat regions that mediate ligand 
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binding. TLRs also contain intracellular Toll/IL-1 receptor (TIR) domains that 
trigger signals via homotypic interactions with proximal adaptor proteins (6, 7). All 
TLRs signal via the adaptor MyD88, leading to activation of NF-KB and mitogen-
activated protein (MAP) kinase pathways. NF-KB activation leads to a tran-
scriptional program that up-regulates proinflammatory gene products such as IL-
1β and TNF-α and, ultimately, to the activation and accumulation of monocytes. 
MyD88 is essential for most TLR-induced NF-KB signaling, as MyD88-deficient 
(MyD88-/-) cells exhibit reduced and delayed NF-KB signaling activity (8, 9). TLR3 
and TLR4 also use another adaptor, TIR domain – containing adaptor inducing 
IFN- β (TRIF). TRIF-dependent signals activate IFN response factor 3 (IRF3) in 
addition to NF-KB (10, 11). These transcription factors induce productive antiviral 
immune responses by binding to promoters of type I IFN and chemotactic genes 
(12).  
 
 Constitutive MyD88-dependent TLR signals provide beneficial, 
noninflammatory signals (2). These signals can also trigger spontaneous 
inflammation. Thus, a major issue arises as to how homeostatic TLR signals are 
distinguished from inflammatory TLR signals. One potential mechanism for 
distinguishing these TLR signals may be related to recent discoveries that 
endogenous proteins such as IL-1R – associated kinase M (IRAK-M), ST2, and 
single Ig and TIR domain (SIGIRR) can restrict TLR signals (13 – 18). These 
proteins can restrict the duration and/or intensity of TLR signals and modulate the 
cellular outcome of TLR signaling, thereby helping to determine whether TLR 
signals lead to homeostatic or inflammatory responses. Notably, mice lacking 
IRAK-M, ST2, and SIGIRR exhibit relatively modest inflammation and survive for 
longer than 9 – 12 mo (14, 16, 17). Suppressor of cytokine signaling (SOCS) 1 
can also inhibit TLR signaling, and SOCS-1-/- mice exhibit severe spontaneous 
inflammation and lymphocyte-mediated perinatal lethality; however SOCS-1-/-mice 
are rescued by the absence of IFN-" signaling in SOCS-1-/-IFN-"-/- double-mutant 
mice (18, 19). Thus, it is unclear whether these proteins restrict TLR signals in 
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unperturbed mice and whether restricting homeostatic TLR signals is important for 
immune homeostasis.  
 A20 is an inducible ubiquitin-editing enzyme that restricts both TLR- and 
TNF-induced responses by regulating the ubiquitylation of key signaling proteins 
(20, 21, 22, 23). A20 deficient (A20-/-) mice spontaneously develop multiorgan 
inflammation, severe cachexia, and premature lethality that can start within 1 – 2 
wk of age, demonstrating the potent antiinflammatory functions of this molecule 
(22). In addition, A20-/-RAG-1-/- double-mutant mice spontaneously develop severe 
inflammation, cachexia, and premature death, indicating that A20 potently 
regulates innate immune homeostasis in the absence of adaptive lymphocytes 
(22). Although A20 is critical for restricting TNF-induced NF-KB signals, both A20-/-
TNF-/-and A20-/-TNFR1-/- double-mutant mice spontaneously develop 
inflammation, cachexia, and premature death, indicating that A20 is critical for 
restricting inflammatory signals independently of TNF/TNFR1 signaling (22).  
 
 A20 expression is rapidly induced in macrophages upon TLR stimulation 
and is required for restricting the duration of TLR-induced NF-KB signaling and the 
quantity of TLR-induced proinflammatory cytokines (22). Hence, A20 functions as 
a negative feedback regulator of exogenous TLR-induced signals. As TLR ligands 
from commensal microorganisms may engage host cells during homeostatic 
conditions, we have investigated the potential roles A20 may play in regulating 
homeostatic TLR signals by interbreeding A20-/-mice with MyD88-/-mice. In 
addition, we have questioned the role of commensal bacteria in driving 
spontaneous inflammation in A20-/-mice. Finally, we have used A20-/-MyD88-/-
double-mutant mice to examine the role of A20 in regulating MyD88-independent 
TLR signals.  
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RESULTS 
 
 
MyD88 deficiency prevents premature lethality and cachexia in A20-/-mice  
 
 As commensal microbes or endogenous ligands may engage host TLRs 
under basal conditions, we investigated whether TLR signals contribute to the 
development of spontaneous inflammation in A20-/- mice by genetically removing 
MyD88-dependent TLR signals. A20-/-mice were interbred with MyD88-/- mice and 
backcrossed at least five generations to C57BL/6. Remarkably, although only 30% 
of A20-/- mice survive to 8 wk of age, nearly 95% of A20-/-MyD88-/- double-mutant 
mice survive past this age (Fig. 1 A). This improved survival rate is similar to that 
of MyD88-/-mice. Additionally, surviving A20-/-MyD88-/-double-mutant animals do 
not exhibit the severe cachexia manifested by surviving A20-/-mice (Fig. 1 B). A20-
/- mice weigh only ≈60% of what wild-type controls weigh, whereas A20-/-MyD88-/-
mice weigh ≈90% of what MyD88-/- controls weigh (Fig. 1 C). These data suggest 
that MyD88 signals drive potent proinflammatory responses that lead to cachexia 
and premature death in the absence of A20.  
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Figure 1. MyD88-dependent cachexia and lethality in A20-/- mice. (A) 
Survival of mice from the indicated genotypes at 8 wk of age (WT, A20 +/-
MyD88+/-; A20 -/- , A20 -/-MyD88+/-; MyD88 -/- , A20 +/-MyD88-/-; and A20-/-MyD88-/-
). The percentage of mice in each cohort that dies before 8 wk of age is indicated 
by the column heights. Total numbers of mice in each cohort are indicated above 
each column.  
(B) Representative 3-mo-old mice from the indicated genotypes. Note the 
cachexia of the A20-/-but not the A20-/-MyD88-/- mouse. (C) Weight of surviving 
mice. Graph represents mean body weights of 10 – 14-wk-old mice from the 
indicated genotypes. Error bars represent standard deviations. Data are 
representative of at least five mice from each genotype.  
 
Homeostatic MyD88-dependent signals activate myeloid cells in A20-/- 
mice  
 
 MyD88-dependent TLR signals activate myeloid cells, leading to the 
production of cytokines that recruit and activate other innate immune cells. A20-/-, 
A20-/-RAG-1-/-double-mutant, A20-/-TNF-/-double-mutant, and A20-/-TNFR1-/- 
double-mutant mice all spontaneously accumulate myeloid cells in both lymphoid 
and nonlymphoid tissues (21, 22). To begin to examine the role of MyD88 in 
causing inflammation in A20 -/-mice, we measured the spleen weights as a 
reflection of the cellularity of these organs. Spleen weights were dramatically 
increased in A20-/-mice when compared with wild-type or MyD88-/-mice (Fig. 2 A), 
and this splenomegaly was particularly impressive given that A20-/- mice were 
significantly smaller than the other genotypes of mice (Fig. 1 C). In contrast, the 
weight of spleens obtained from double-deficient A20 -/-MyD88-/-mice was 
significantly less than that obtained from A20 -/-mice and more closely 
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approximated the weight of spleens obtained from wild-type and MyD88-/- mice 
(Fig. 2 A.) 
 
 
 
 
Figure 2. Reduced myeloid accumulation and splenomegaly in A20-/-MyD88-/-
mice. (A) Spleen weights from 6 – 8-wk-old mice of the indicated genotypes. (B) 
Total numbers of Mac1+ Gr1+ myeloid cells (activated macrophages and 
granulocytes) from spleens of mice of the indicated genotypes. (C) Representative 
flow cytometric analysis of Mac-1+ Gr-1+ myeloid cells from peripheral and 
mesenteric lymph nodes and spleens from mice of the indicated genotypes. Note 
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the decreased frequency and numbers of myeloid cells in lymphoid organs from 
A20-/-MyD88-/-mice compared with A20-/- mice. Numbers indicate the percentage 
of live Mac-1+ Gr-1+ splenocytes within the indicated gates. (D) ELISA analyses 
of IL-6 levels in serum from mice of the indicated genotypes. Error bars represent 
standard deviations. Data are representative of at least five mice from each 
genotype. 
 
  
 To further examine the cellular nature of MyD88-dependent inflammation in 
A20 -/- mice, we performed flow cytometric analyses of tissues from these wild-
type, A20-/-, MyD88-/-, and A20-/-MyD88-/- mice. These studies revealed that 
significantly greater numbers and percentages of myeloid (Mac1+ Gr1+) cells 
accumulate spontaneously in spleens of A20-/- mice when compared with wild-type 
mice, whereas the numbers of these cells obtained from A20-/-MyD88-/- mice were 
significantly less than those obtained from A20-/- mice and more closely 
approximated the numbers obtained from wild-type and MyD88-/- mice (Fig. 2, B 
and C).  
 
 Myeloid cells were selectively expanded in tissues of A20-/- mice at the cost 
of other cells, as the percentage of Mac1+ Gr1+ cells was increased when 
compared with wild-type or MyD88-/-mice (Fig. 2 C). This expansion was also 
largely (but not completely) ameliorated in A20-/-MyD88-/- mice. To assess the 
functional activation of myeloid cells such as macrophages, we measured serum 
levels of IL-6 in these mice. Serum IL-6 levels were dramatically elevated in A20-/- 
mice, as compared with MyD88-/- or wild-type mice, whereas A20-/- MyD88-/- mice 
had undetectable levels of IL-6 (Fig. 2 D). These findings indicate that A20 
prevents spontaneous activation and recruitment of innate immune cells in mice 
by restricting homeostatic MyD88-dependent signals.  
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Homeostatic MyD88-dependent signals activate T cells in A20-/- mice  
 
 TLR-dependent signals play important roles in inducing adaptive immune 
response during microbial infections (24, 25). For example, MyD88-dependent 
signals on antigen-presenting cells support the activation and expansion of T 
cells. To determine whether basal MyD88-dependent signals cause spontaneous 
activation and expansion of T cells in unperturbed A20 -/-mice, we examined the 
number and activation state of T cells from A20-/-, A20-/-MyD88-/-, and control mice. 
Significantly greater percentages (and total numbers) of activated, memory 
phenotype (CD44Hi CD62LLo) T cells were present in lymph nodes and spleens of 
A20-/-mice when compared with wild-type mice (Fig. 3 A and not depicted). In 
contrast, T cells from A20-/-MyD88-/- double-mutant mice were less activated than 
those from A20-/- mice and were more comparable to wild-type and MyD88-/- mice. 
This reduction in spontaneous T cell activation was observed in both CD4+ and 
CD8+ T cell populations (Fig. 3, B and C). This finding suggests that homeostatic 
MyD88-dependent signals cause T cell activation in the absence of A20. 
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Figure 3. MyD88 dependence of T cell hyperactivation in A20-/- mice. (A) Flow 
cytometric analyses of T cell phenotypes from peripheral lymph nodes from 5 – 6-
wk-old mice of the indicated genotypes. Representative FACS plots of CD4 + T 
cells. The numbers represent the percentages of CD4+ T cells that are CD44Hi and 
CD62L Lo (boxed gates), indicating an effector/memory T cell phenotype. Note the 
increased frequency of activated CD4+ T cells in A20-/- animals, and the reduced 
percentages of activated T cells in A20-/-MyD88-/-mice. (B) Quantitation of 
activated CD4+ (CD44Hi CD62LLo) T cells. (C) Quantitation of activated CD8+ T 
cells. Error bars represent standard deviations. Data are representative of at least 
three mice per genotype.  
 
 
Homeostatic MyD88-dependent signals in radiation sensitive 
hematopoietic cells drive myeloid cell activation in A20-/- mice  
 
 Hematopoietically derived cells such as macrophages and dendritic cells 
are able to sample surrounding microflora and transmit basal proinflammatory 
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signals. In addition, A20 and MyD88 are both expressed in epithelial cells and 
stromal cells, which can also respond to TLR ligands. Thus, A20ʼs role in 
restricting MyD88-dependent signals could involve signals on either hematopoietic 
cells, stromal cells, or both. To isolate the potential role of A20 in regulating 
MyD88 signaling in hematopoietic cells, Ly5.2 C57BL/6 mice were lethally 
irradiated and reconstituted with bone marrow hematopoietic stem cells (HSCs) 
from either wild-type, A20-/-, MyD88+/+, MyD88-/-, or A20-/-MyD88-/- mice. Flow 
cytometric analyses of tissues from these chimera were then performed 6 wk after 
reconstitution. Similar to our findings with intact mice, spleens from radiation 
chimera reconstituted with A20-/- HSCs contained increased numbers of various 
myeloid cell types when compared with chimera reconstituted with wild-type HSCs 
(Fig. 4 A).  
 
 The myeloid cells that expand in A20-/- HSC-reconstituted chimera spleens 
include various myeloid populations such as macrophages (Mac-1+, F480+, and 
Siglec F-), neutrophils (Mac-1+, Gr-1+, F480-, and Siglec F-), and eosinophils (Mac-
1+, Siglec F+, and SSCHi) without any particular skewing toward particular subsets 
(Fig. 4 A). The absolute numbers of these populations were generally reduced in 
A20-/-MyD88-/- HSC-reconstituted chimera compared with A20-/- HSC-reconstituted 
chimera, although some of these reductions were less dramatic than the 
differences observed in intact A20 -/-MyD88+/+ and A20-/-MyD88-/- mice (Figs. 2 
and 4 A). To further characterize the nature of the spontaneous inflammation 
caused by A20-/-hematopoietic cells in these chimera, we analyzed splenic 
production of cytokines. These studies revealed that spleens from A20-/- HSC-
reconstituted chimera produced elevated levels of TNFα and IL-1β (Fig. 4 B).  
These indicators of spontaneous inflammation were absent in A20-/-MyD88-/- HSC-
reconstituted chimera (Fig. 4 B). As IL-10 – deficient mice have recently been 
described to develop spontaneous colitis that resolves in the absence of MyD88 
signals (3), we examined whether A20-/- HSC-reconstituted chimera were IL-10 
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deficient. A20-/- mice expressed elevated levels of IL-10, suggesting that IL-10 
deficiency does not contribute to spontaneous inflammation in A20-/- mice (Fig. 4 
B). A20-/- HSC-reconstituted chimera also expressed normal levels of IL-2 and 
possessed normal numbers of functional regulatory T cells (Fig. 4 B and not 
depicted). Thus, IL-2 deficiency is also unlikely to explain the spontaneous 
inflammation in A20-/- mice. Finally, A20-/- HSC-reconstituted chimera expressed 
elevated levels of IL-13 as well as the prototypical Th1 cytokines TNFα and IFN-γ 
(Fig. 4 B and not depicted). Hence, no gross evidence of Th1 or Th2 skewing is 
evident in these mice.  
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Figure 4. A20 expression in hematopoietic cells restricts MyD88-driven 
spontaneous inflammation in radiation chimera. (A) Flow cytometric analyses 
of chimeric mice generated by transfer of A20+/-MyD88+/-, A20 -/-MyD88+/+, A20 +/+ 
MyD88-/-, or A20-/-MyD8-/- bone marrow HSCs into lethally irradiated C57BL/6J 
456 A20-MEDIATED RESTRICTION OF HOMEOSTATIC M Y D88 SIGNALS | Turer et al.
 Figure 4.  A20 expression in hematopoietic  cells restricts MyD88-driven spontaneous in! ammation in radiation chimera. (A) Flow cytometric 
analyses of chimeric mice generated by transfer of A20 +/ !  MyD88 +/ !  , A20  ! / !  MyD88 +/+ , A20 +/+ MyD88  ! / !  , or A20  ! / !  MyD8  ! / !  bone marrow HSCs into 
lethally irradiated C57BL/6J mice. 6 wk after reconstitution, spleens from chimeric mice were analyzed by ! ow cytometry for the number of the indicated 
myeloid cell types (Mac1 + Gr1 + , activated macrophages and neutrophils; Mac1 + F4/80  !  Gr1 + , neutrophils; Mac1 + F4/80 + Siglec F  !  , macrophages; and 
F4/80 + Siglec F + SSC Hi , eosinophils). The numbers of Mac-1 + , Mac-1 + Gr-1 + , and Mac-1 + F4/80  !  Gr-1 + cells were statistically different (P  < 0.05) between 
A20  ! / !  and A20  ! / !  MyD88  ! / !  mice. (B) Quantitative real-time PCR analyses of mRNA levels of the indicated cytokines in spleens from chimeric mice. 
Splenic expression lev ls of the ndicated cytokines are shown in R.U. for the chimeric mice described in A. All cytokine mRNA levels were normalized 
to  " -actin mRNA. The levels of cytokines were statistically different between A20  ! / !  and A20  ! / !  MyD88  ! / !  mice for all cytokines. Error bars indicate 
standard deviations. Graphs display results from at least three independent mice per genotype. 
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mice. 6 wk after reconstitution, spleens from chimeric mice were analyzed by flow 
cytometry for the number of the indicated myeloid cell types (Mac1+ Gr1+, 
activated macrophages and neutrophils; Mac1+ F4/80-Gr1+, neutrophils; Mac1+ 
F4/80+ Siglec F -, macrophages; and F4/80+ Siglec F+ SSCHi, eosinophils). The 
numbers of Mac-1+, Mac-1 + Gr-1+, and Mac-1+ F4/80-Gr-1+ cells were statistically 
different (P < 0.05) between A20-/-and A20-/-MyD88-/-mice. (B) Quantitative real-
time PCR analyses of mRNA levels of the indicated cytokines in spleens from 
chimeric mice. Splenic expression levels of the indicated cytokines are shown in 
R.U. for the chimeric mice described in A. All cytokine mRNA levels were 
normalized to β-actin mRNA. The levels of cytokines were statistically different 
between A20-/-and A20 -/-MyD88-/- mice for all cytokines. Error bars indicate 
standard deviations. Graphs display results from at least three independent mice 
per genotype.  
 
Collectively, these data suggest that homeostatic MyD88 signals in hematopoietic 
cells drive a broad spectrum of spontaneous proinflammatory pathways in the 
absence of A20.  
 
 
Commensal bacteria stimulate homeostatic MyD88-dependent signals  
 
 Homeostatic MyD88-dependent signals may be derived from host 
molecules or from commensal microbes that express TLR ligands and are in 
constant contact with host cells. By far, the most abundant source of commensal 
microbes is the intestinal lumen. Thus, to determine whether commensal intestinal 
microbes stimulate the homeostatic MyD88-dependent signals that drive 
inflammation in A20-/- mice, we first generated radiation chimera using HSCs from 
A20+/+ and A20-/- bone marrows. 2 wk after irradiation, we treated these chimera 
with oral broad spectrum antibiotics previously shown to markedly reduce the 
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number of intestinal bacteria (vancomycin, neomycin, metronidazole, ampicillin, 
and trimethoprim-sulfamethoxazole). After 3 wk of treatment with this antibiotic 
cocktail (or with trimethoprim-sulfamethoxazole alone as a control), chimeric mice 
were analyzed for the numbers of intestinal bacteria as well as for evidence of 
spontaneous inflammation. Chimera reconstituted with A20-/- HSCs developed 
spontaneous cachexia and lost weight when compared with chimera reconstituted 
with wild-type HSCs (Fig. 5 A). These results suggest that A20-/- hematopoietic 
cells recapitulate the spontaneous inflammation observed in intact A20-/- mice. 
Chimera treated with the cocktail of broad spectrum antibiotics possessed several 
orders of magnitude fewer intestinal bacteria (not depicted). In contrast with A20-/- 
HSC-reconstituted chimera treated with trimethprim-sulfamethoxazole alone, A20-
/- HSC-reconstituted chimera treated with the cocktail of broad spectrum antibiotics 
maintained their weight (Fig. 5 A). Thus, antibiotic treatment prevents cachexia 
caused by A20 deficiency. Large numbers of Mac1+ Gr1+ myeloid cells 
spontaneously accumulated in the spleens of A20-/- HSC-reconstituted chimera but 
not in spleens from antibiotic-treated A20-/- HSC-reconstituted chimera (Fig. 5 B). 
Finally, spleens from A20 -/-HSC-reconstituted chimera spontaneous produced 
elevated levels of IL-6 and TNF messenger RNAs (mRNAs) compared with 
spleens from wild-type HSC-reconstituted chimera (Fig. 5 C). These indicators of 
inflammation were ameliorated in A20-/- HSC-reconstituted chimera treated with 
broad spectrum antibiotics (Fig. 5 C). Collectively, these results indicate that 
commensal intestinal bacteria drive spontaneous cachexia and myeloid 
inflammation via MyD88 signals in the absence of A20.  
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Figure 5. Depletion of commensals with broad-spectrum antibiotics 
diminishes inflammation driven by A20-/- hematopoietic cells. Chimeric mice 
were generated from transfer of A20+/+ (WT) or A20-/- Ly5.1+ bone marrow HSCs 
into sublethally irradiated congenic Ly5.2+ C57BL/6J mice. 2 wk after irradiation, 
animals were given 0.5 gram per liter of vancomycin, 1 gram per liter of ampicillin, 
1 gram per liter of neomycin, 1 gram per liter of metronidazole, and trimethoprim-
sulfamethoxazole in drinking water for 3 – 4 wk (+Abx) or maintained on 
trimethoprim-sulfamethoxazole (Ctrl) for the same period. (A) The percent weight 
change of chimeric mice reconstituted with HSCs of the indicated genotypes and 
treated with either broad spectrum (+Abx) or control antibiotics (Ctrl). The percent 
change was calculated by dividing the weight of each mouse on the day of 
death/analysis by the weight on the day of irradiation and HSC reconstitution. (B) 
Flow cytometric analyses of Ly5.1+ Mac1+ Gr1+ cells from spleens of chimeric 
mice. (C) Quantitative real-time PCR analysis of mRNA levels of IL-6 and TNF in 
spleens of chimeric mice. Note that A20-/- HSC-reconstituted chimera 
spontaneously lose weight, accumulate myeloid cells, and express higher levels of 
splenic IL-6 and TNF than A20+/+ HSC-reconstituted chimera, whereas treatment 
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of A20-/- HSC-reconstituted chimera with broad spectrum antibiotics prevents 
these signs of inflammation. Error bars represent standard deviations. Data are 
representative of five mice. 
 
 
TRIF-dependent TLR signals are restricted by A20  
 
 In the absence of the TLR adaptor MyD88, TLR3 and TLR4 signal through 
an alternate adaptor protein, TRIF. TRIF-dependent responses lead to the 
production of type I IFNs (IFN-α and IFN-β) and are critical for productive antiviral 
immunity (10, 11). We thus asked whether A20 was physiologically required for 
restricting TRIF-dependent TLR responses. To examine this question, we injected 
LPS intraperitoneally into either A20-/-MyD88-/- or MyD88-/- HSC-reconstituted 
chimeric mice and measured the resulting TRIF-dependent inflammatory 
response. We first measured the production of IFN-β and monocyte 
chemoattractant protein (MCP) 1, two TRIF-dependent proinflammatory cytokines 
that are produced by macrophages and dendritic cells. Quantitative real-time PCR 
analysis of splenocytes from these mice revealed that IFN-β and MCP-1 
expression are induced by LPS to a greater degree in A20-/-MyD88-/- HSC-
reconstituted chimera than in MyD88-/- HSC-reconstituted chimera (Fig. 6 A). To 
assess the role of A20 in regulating MyD88-independent recruitment of 
granulocytes to LPS, we quantitated the number of Mac-1+ Gr-1+ F4/80-cells 
(neutrophils) recruited to the peritoneal cavity 2 h after LPS injection. These 
experiments indicated that far greater numbers of these cells were obtained from 
the peritoneal lavage of LPS-stimulated A20-/-MyD88-/- HSC-reconstituted chimera 
than from MyD88-/- HSC-reconstituted chimera (Fig. 6 B). We also measured the 
production of MCP-1 protein in peritoneal lavages from these mice by ELISA and 
found that MCP-1 protein was produced at higher levels in A20-/-MyD88-/- HSC-
reconstituted chimera than in MyD88-/- HSC-reconstituted chimera (Fig. 6 C).  
Finally, IFN- β stimulates IL-15 and IL-15Rα production, leading to NK cell 
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activation in early antiviral immunity. Soluble IL-15Rα is released into the serum 
during this process (unpublished data). We thus measured serum IL-15Rα protein 
levels in LPS-stimulated chimeric mice by ELISA, and these assays showed that 
higher levels of soluble IL-15Rα were present in LPS-stimulated A20-/-MyD88-/- 
chimera than in LPS-stimulated MyD88-/- chimera (Fig. 6 D). Collectively, these 
findings indicate that A20 is physiologically required for restricting acute, MyD88-
independent, TRIF-dependent proinflammatory signals in vivo.  
 
 
Figure 6. A20 expression in hematopoietic cells restricts TRIF-dependent 
LPS responses in vivo. Chimeric mice were generated using HSCs of the 
indicated genotypes and lethally irradiated C57BL/6J mice. 6 wk after 
reconstitution, chimeric mice were injected with 100 μ g LPS or PBS (mock) 
intraperitoneally and killed after 2 h. (A) Real-time PCR analyses of IFN-β and 
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MCP-1 mRNA levels in splenocytes from the indicated mice. mRNA levels were 
normalized to GAPDH mRNA and expressed as R.U. (B) Flow cytometric 
analyses of the number of Mac1+ Gr1+ F4/80-neutrophils recruited to the peritoneal 
cavities of the indicated mice. Absolute numbers of neutrophils obtained in 5 ml of 
peritoneal lavage are shown. (C) ELISA determination of levels of MCP-1 protein 
obtained in peritoneal lavages of mice of the indicated genotypes. (D) ELISA 
determination of soluble IL-15R a levels measured in the serum of the indicated 
mice. Error bars represent standard deviations. Data are representative of three 
mice in each treatment group.    
 
 
 
A20 regulates TRIF-dependent TLR-induced NF-KB signaling but not 
IRF3 signaling  
 
 TRIF-dependent TLR signals involve both NF-KB and IRF3-dependent 
signals (26, 27). To determine how A20 regulates TRIF-dependent TLR 
responses, we first interbred A20 -/MyD88-/-mice with TNF-/-mice. The resulting 
triple-mutant mice allowed us to evaluate TRIF-dependent TLR signals in the 
absence of secondary TNF signaling. We then prepared bone marrow – derived 
macrophages (BMDMs) from these TNF-/-MyD88-/-and A20-/-TNF-/-MyD88-/-mice. 
 Comparable numbers and phenotypes of these two types of BMDMs were 
obtained after 6 d of culture in MCSF-supplemented media (not depicted). We 
then tested the responses of these cells to LPS or poly-inosine:cytosine (poly 
(I:C)), ligands for TLR4 and TLR3, respectively. After either of these stimuli, A20-/-
TNF-/-MyD88-/- BMDMs secreted greater amounts of IFN-β than TNF-/-MyD88-/- 
BMDMs (Fig. 7 A and not depicted). Thus, A20 appears to be directly required for 
restricting TRIF-dependent TLR responses independently of TNF signaling.  
The production of IFN-β is dependent on both NF-KB as well as IRF3 signaling, 
as the IFN-β promoter contains binding elements for both these transcription 
factors. To further understand the mechanism by which A20 restricts TRIF-
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dependent TLR signaling, we stimulated A20-/-TNF-/-MyD88-/-and TNF-/-MyD88-/-
BMDMs with LPS, prepared whole-cell lysates at various time points, and 
analyzed these lysates for the expression of IκBα and phospho-IκBα by 
immunoblotting. When compared with TNF-/-MyD88-/-BMDMs, A20-/-TNF-/-MyD88-/-
cells exhibited prolonged expression of phospho-IκBα and delayed recovery of 
IκBα, indicating that A20 is required for restricting TRIF-dependent NF-κB 
signaling (Fig. 7 B).  
 In addition to activating NF-κB signaling, TLR3- and TLR4-induced 
activation of TRIF also causes IRF3 phosphorylation, which in turn leads to its 
dimerization, nuclear translocation, and stimulation of IFN- α/β gene transcription 
(12). TNF-/-MyD88-/- and A20-/-TNF-/-MyD88-/- BMDMs were stimulated with LPS for 
various time periods. Phospho-IRF3 levels were then measured by 
immunoblotting of nuclear protein extracts. Surprisingly, TNF-/-MyD88-/- and A20-/-
TNF-/-MyD88-/- BMDMs activated phospho-IRF3 with similar kinetics and intensity 
(Fig. 7 C). Thus, A20 is required for restricting TRIF-dependent NF-κB signaling 
but not TRIF-dependent IRF3 signaling. Moreover, these data suggest that 
increased IFN-β production from A20-/-TNF-/-MyD88-/- BMDMs, when compared 
with A20+/+ TNF-/-MyD88-/- BMDMs, is caused by increased NF-κB signaling and 
not increased IRF3 signaling.  
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Figure 7. A20 is critical for directly restricting MyD88-independent LPS 
responses. (A) ELISA analysis of IFN-β secretion by LPS-stimulated BMDMs. 
TNF-/-MyD88-/- and A20-/-TNF-/-MyD88-/- BMDMs were stimulated for 24 h with LPS, 
after which supernatants were harvested for ELISA. (B) Immunoblotting analyses 
of phospho-IκBα and IκB protein expression by LSP-stimulated BMDMs. TNF-/-
MyD88-/- and A20-/-TNF-/-MyD88-/- BMDMs were stimulated with LPS for the 
indicated times, after which cells were lysed for immunoblotting analyses for the 
indicated proteins. Actin protein levels are shown as a loading control. (C) 
Immunoblotting analyses of nuclear lysates for phospho-IRF3 protein expression 
by LPS-stimulated BMDMs. Nuclear USF2 protein levels are shown as a control. 
The black line indicates that intervening lanes have been spliced out. Data are 
representative of at least three experiments.  
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A20 is essential for restricting TLR-induced TNF receptor – associated 
factor (TRAF) 6 ubiquitination 
 
 Our previous studies showed that A20 restricts TLR-induced NF-κB 
signaling (22). Our current studies indicate that A20 regulates TRIF-dependent 
NF-κB signaling but not IRF3 signaling. Collectively, these data suggest that the 
major function of A20 in TLR signaling is to directly regulate a signaling event that 
is common to MyD88- and TRIF-dependent NF-κB signaling and that is not 
shared by TRIF-dependent IRF3 signaling. TRAF6 is an E3 ligase that is involved 
in both MyD88- and TRIF-dependent NF-κB signaling (28 – 30). Upon stimulation 
with TLR ligands, TRAF6 is recruited to the TLR in both MyD88-dependent and -
independent signaling pathways. TRAF6 autoligates lysine-63 ubiquitin chains 
upon TLR or IL-1R stimulation to activate NF-κB, and our previous studies showed 
that A20 is able to use its OTU protease domain to deubiquitylate TRAF6 (22, 30). 
Thus, TRAF6 may be a physiological target for A20 during TLR signaling. To 
directly determine if A20 is essential for regulating TRAF6 ubiquitylation during 
TLR stimulation, A20+/+ and A20-/-BMDMs were stimulated with LPS for various 
periods of time, after which cell lysates were analyzed for their expression of 
ubiquitylated TRAF6. Endogenous TRAF6 is ubiquitylated after 20 min of LPS 
stimulation (Fig. 8). Importantly, whereas TRAF6 ubiquitylation is transiently 
induced in A20+/+ cells, declining after 40 min, TRAF6 ubiquitylation is prolonged 
to 40 and 60 min in A20-/- cells (Fig. 8). As these lysates were boiled in 1% SDS 
before immunoprecipitation of TRAF6, the ubiquitylated proteins we observe are 
likely to be predominantly ubiquitylated TRAF6 rather than noncovalently 
associated proteins. This finding indicates that A20 is essential for restricting 
endogenous TRAF6 ubiquitylation after TLR stimulation.  
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Figure 8. A20 is essential for restricting TRAF6 ubiquitylation. 
Immunoblotting analysis of endogenous TRAF6 ubiquitylation in LPS-stimulated 
BMDMs. A20-/-and A20+/+ BMDMs were stimulated with LPS, and cell lysates were 
generated at the indicated time points. Samples were boiled in 1% SDS to 
disassociate noncovalent protein – protein interactions. After dilution to 0.1% SDS, 
TRAF6 protein was immunoprecipitated from the lysates and immunoblotted for 
ubiquitin. Data are representative of at least three independent experiments.  
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DISCUSSION  
 
 
 Our studies have shed new light on the importance and regulation of 
homeostatic TLR signals. Recent studies have indicated that homeostatic TLR 
signals may be chronically triggered by PAMPs from microbes at mucosal 
surfaces such as the intestinal epithelium. MyD88-dependent TLR signals may be 
beneficial for intestinal homeostasis under normal circumstances (2, 31). The 
appreciation of such homeostatic TLR signals has raised several questions, 
including whether homeostatic TLR signals are potentially inflammatory. Our 
finding that unperturbed A20-/-MyD88-/- mice are dramatically less inflamed and 
survive far longer than A20 -/-MyD88+/-mice suggests that homeostatic TLR signals 
can in fact be profoundly inflammatory and rapidly lethal. We have also elucidated 
a new function for A20 in regulating TRIF-dependent NF-κB signals but not IRF3 
signals.  
 
  The idea that homeostatic MyD88 signals can cause spontaneous 
inflammation is broadly consistent with recent findings that constitutive MyD88 
signals drive colitis and eventual mortality in IL-10-/- mice (3). However, although 
IL-10-/- mice develop progressive colitis during the first 4 – 6 mo of life and 
eventually die from this disease, the majority of A20-/-mice die within the first 3 – 6 
wk of life from widespread systemic inflammation and cachexia (3, 32). Thus, our 
findings indicate that homeostatic MyD88 signals can drive severe perinatal 
systemic inflammation in addition to intestinal inflammation. Moreover, although 
IL-10 is particularly important for restricting intestinal inflammation, A20 is critical 
for restricting systemic inflammation.  
 
 Although A20 prevents widespread inflammation, a major source of 
constitutive, proinflammatory TLR signals in A20-/- mice may nevertheless be 
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intestinal commensal bacteria. We have found that the removal of many of these 
bacteria with antibiotics reduced systemic inflammation in chimeric mice bearing 
A20-/-hematopoietic cells. Although previous studies have shown that intestinal 
bacteria can drive intestinal inflammation in several models (33), our current 
results link these bacteria and MyD88-dependent signals to A20-mediated 
regulation of innate immune cells and to systemic immune activation.  
 
 The different physiological roles of IL-10 and A20 in restricting MyD88-
dependent signals is likely related to the distinct biochemical functions of these 
immunoregulatory proteins. IL-10 triggers STAT3-mediated transcriptional 
inhibition of proinflammatory genes, whereas our data indicate that A20 restricts 
MyD88-dependent TLR signals by regulating TRAF6 ubiquitylation. Thus, the 
critical physiological role that A20 plays in preventing constitutive homeostatic 
MyD88 signals from becoming inflammatory is likely caused by A20ʼs biochemical 
role in directly regulating MyD88-dependent signals.   
 Proteins such as A20, IRAK-M, ST2, and SIGIRR that restrict TLR signals 
could regulate the duration and/or intensity of TLR signals and modulate the 
cellular outcome of TLR signaling, thereby helping to determine whether TLR 
signals lead to homeostatic or inflammatory responses (14 – 18). Notably, 
although unperturbed mice lacking IRAK-M, ST2, and SIGIRR exhibit relatively 
modest inflammation and survive for longer than 9 – 12 mo of age, A20-/- mice 
typically die within the first few weeks of life (13 – 17). Although SOCS-1 -/-mice 
exhibit perinatal lethality similar to A20-/- mice, SOCS-1-/- mice are rescued by the 
absence of IFN-γ signaling in SOCS-1-/-IFN-γ-/- double-mutant mice (19 – 21). 
Thus, among proteins known to directly restrict TLR signaling, A20 appears to 
play a more critical role in regulating homeostatic TLR-driven inflammation in vivo. 
There are several potential (non-mutually exclusive) reasons why A20 has a 
greater physiological impact on homeostatic TLR signals. First, A20 enzymatically 
regulates ubiquitylation of signaling proteins, thereby regulating both the activity 
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and stability of such targets. Thus, A20 may not only deactivate signaling proteins 
but may also prevent further reactivation of these proteins. Second, A20 may 
regulate TLR signaling downstream of other known TLR regulating proteins, thus 
exerting a more definitive impact on the transcriptional outcome of TLR signals. 
Third, A20ʼs physiological roles in restricting MyD88-dependent TLR signals may 
be amplified by A20ʼs roles in regulating other non-TLR signals, e.g., TNF signals. 
However, marked survival differences between A20-/-MyD88-/-TNF-/- mice and A20-
/-TNF-/- mice suggest that restricting MyD88 signals may be the dominant 
physiological function of A20 during homeostatic conditions. Finally, it is possible 
that A20 may also regulate IL-1 or IL-18 signals, which also use MyD88 (9). 
Although we have not yet evaluated the contribution of aberrant IL-1 or IL-18 
signaling to spontaneous inflammation in A20-/- mice, IL-1 receptor antagonist – 
deficient mice do not develop spontaneous inflammation within the first 4 mo of life 
(34). Thus, restricting basal IL-1 signals may not be critical for immune 
homeostasis in unperturbed mice. Collectively, A20 appears to be one of the most 
critical proteins for restricting homeostatic TLR signals in vivo.   
 Constitutive or basal MyD88-dependent signals could derive from microbial 
or host ligands. Our experiments with antibiotic-mediated depletion of commensal 
bacteria reinforce the notion that intestinal bacteria are a major source of MyD88-
dependent signals triggering inflammation in unperturbed A20-/- mice. Collectively 
with previous findings that constitutive MyD88-dependent signals from luminal 
bacteria are required for maintaining intestinal health, the current results suggest 
that a moderate but not excessive magnitude of MyD88 signaling in the intestine is 
essential for intestinal homeostasis.  
 
 In the intestine, homeostatic TLR signals might also be distinguished from 
inflammatory TLR signals by microenvironment- and cell type – specific TLR 
signals. For example, apical TLR signals on epithelial cells might preferentially 
induce homeostatic signals, whereas TLR signals on dendritic cells trigger 
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inflammation. Although we have not yet directly addressed the roles of A20 in 
regulating epithelial cell function, our discoveries that radiation chimera bearing 
A20-/-MyD88-/-hematopoietic cells exhibit less spontaneous inflammation than 
chimeric mice bearing A20-/-MyD88+/+ cells indicates that A20-mediated restriction 
of homeostatic TLR signals specifically in hematopoietic cells is important for 
immune homeostasis. Although it is possible that TLRs on epithelial cells may also 
be constitutively engaged on mucosal surfaces, our results using radiation 
chimera indicate that engagement of TLRs on hematopoietic cells occurs in 
unperturbed mice and must be properly restricted to maintain immune 
homeostasis. Indeed, one example of how TLRs on hematopoietic cells might 
tonically bind PAMPs from luminal microbes is via the extrusion of dendrites by 
mucosal dendritic cells through epithelial tight junctions into the intestinal lumen 
(35 – 37). Future studies using gene-targeted mice bearing lineage-specific 
deletions of A20 should facilitate studies of A20ʼs specific role in dendritic cells 
and other cell types.  
 
 The generation and characterization of A20-/-MyD88-/-mice also facilitates 
further studies of A20ʼs roles in regulating additional signaling pathways. Milder 
but progressive spontaneous inflammation in older double-mutant A20 -/-MyD88-/- 
mice and triple-mutant A20-/-MyD88-/-TNF-/- mice suggests that A20 regulates 
additional immune signals besides MyD88-dependent TLR and TNF signals. 
TRIF-dependent TLR signals may be one of these types of signals, and we have 
used A20-/-MyD88-/-mice to discover that A20 is also required for restricting TRIF-
dependent TLR responses. We have also used A20-/-MyD88-/- and A20-/-MyD88-/-
TNF-/- cells to decipher the biochemical mechanism by which A20 regulates TLR 
signaling. Specifically, both A20-/-MyD88-/- mice and BMDMs derived from these 
mice produce more type I IFNs than A20+/-MyD88-/-mice and BMDMs after LPS 
stimulation. Previous work demonstrated that TRIF associates with TANK-binding 
kinase 1, TRAF3, and TRAF6 during the activation of NF-κB and IRF3 signaling 
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(10, 38). Both NF-κB and IRF3 are required for TRIF-dependent IFN transcription. 
Receptor-interacting protein (RIP) 1 ubiquitylation, possibly mediated by TRAF6, 
is also involved in TRIF-dependent NF-κB signaling (39, 40). Our data suggest 
that A20 restricts TRIF-dependent NF-KB signaling and not IRF3 phosphorylation. 
Hence, A20ʼs nonredundant function in regulating TRIF-dependent signaling 
appears to be restricted to NF-κB signaling. A20 can inhibit TLR3 signals and can 
bind TRAF6, Nef-associated kinase/TANK-binding kinase 1, and IκB kinase e (41 
– 43). Thus, it is likely that A20 restricts TRIF-dependent signaling by directly 
regulating proteins in this signaling complex. Our data do not support the previous 
finding that heterologous A20 expression inhibits IRF3 dimerization, and these 
differences could be caused by the distinct experimental systems used (43). 
Collectively, our data suggest that A20 restricts TRIF-dependent IFN responses 
by limiting TRIF-dependent NF-κB signaling.  
 
 Previous work has shown that conjugation of K63-linked ubiquitin chains to 
TRAF6 is an essential step in TLR-induced NF-KB activation (30). Our earlier 
studies also showed that A20 is a ubiquitin-modifying enzyme that can both 
deconjugate ubiquitin chains and ligate ubiquitin onto target proteins such as RIP 
and TRAF6 (18, 23). Our current data directly demonstrate that A20 is essential 
for restricting endogenous TRAF6 ubiquitylation after TLR stimulation, further 
reinforcing this biochemical mechanism. As TRAF6 binds to both MyD88 and 
TRIF after TLR stimulation, TRAF6 likely activates NF-κB signals in both of these 
pathways. RIP1 is also involved in TRIF-dependent TLR signaling, and A20 
restricts RIP1 ubiquitylation in response to TNF (39, 40). Thus, it is possible that 
A20 also restricts TRIF-dependent NF-κB signaling by restricting RIP1 
ubiquitylation. However, RIP1 is not involved in MyD88-dependent NF-κB 
signaling, so it is unlikely that A20ʼs effects on RIP1 can explain all of A20ʼs roles 
in TLR signaling. In contrast, A20ʼs restriction of TRAF6 ubiquitylation may be a 
common mechanism by which A20 restricts both MyD88- and TRIF-dependent 
NF-κB signaling.  
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 TRAF3 has recently been implicated in TRIF-dependent signaling (44, 45). 
TRAF3 appears to be more important for IRF signals, whereas TRAF6 is more 
important for NF-KB signaling. We and others have not been able to obtain 
evidence that A20 binds to or modifies TRAF3 (unpublished data), and our finding 
that IRF3 phosphorylation occurs normally in the absence of A20 suggests that 
A20 may preferentially regulate TRAF6- but not TRAF3-dependent signaling. 
These two proteins (along with TRAF2, TRAF4, and TRAF5) share structurally 
homologies, including RING and Zn finger motifs that may mediate E3 ligase 
activity. Selective regulation of TRAF6-but not TRAF3-dependent signaling by A20 
might be explained if A20 preferentially binds TRAF6 rather than TRAF3. 
Alternatively, although TRAF6 is modified with K63-linked polyubiquitin chains 
during TLR initiated signal transduction, it is currently unclear if TRAF3 is similarly 
ubiquitylated. Thus, A20 may bind K63 polyubiquitylated TRAF6, whereas TRAF3 
may not undergo this type of ubiquitylation modification. In either scenario, our 
findings indicate that A20 is a selective regulator of TRAF6- and not TRAF3-
dependent signal transduction and provides new insights into how NF-κB and IRF 
signaling may be discriminated and differentially regulated.  
 
Our finding that A20 -/-MyD88-/- mice virtually all survive to adulthood with 
modest amounts of inflammation contrasts sharply with our previous findings that 
A20-/-, A20-/-RAG-1-/-, A20-/-TNF-/-, and A20-/-TNFR1-/- mice all spontaneously 
develop severe inflammation, cachexia. and premature death (18, 19). This result 
suggests that dysregulated homeostatic TLR signals stimulate downstream innate 
and adaptive immune signals in the absence of A20 (e.g., TNF, IL-12, IL-6, and 
chemokine production, T cell activation, B cell activation, etc). Although A20 may 
play multiple important roles in regulating immune cell signals, its role in restricting 
homeostatic TLR signals may be physiologically critical because TLR signals are 
situated at the apex of immune responses. Moreover, our results showing that 
antibiotics ameliorate inflammation in A20-/- chimeric mice suggest that 
commensal intestinal flora trigger these homeostatic MyD88-dependent TLR 
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signals. Finally, we have established a biochemical mechanism by which A20 
restricts both MyD88- and TRIF-dependent TLR signals. In summary, our findings 
demonstrate the profoundly pro-inflammatory nature of homeostatic MyD88-
dependent signals and identify A20 as a critical protein that prevents homeostatic 
signals from becoming inflammatory. Further studies elucidating how A20 restricts 
different types of TLR signals should yield important insights into the complex 
interplay between commensal microbes and host immune cells, as well as the 
biochemical mechanisms by which signals triggered by microbial molecules are 
regulated and interpreted.  
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MATERIALS AND METHODS  
 
 
Mice and cell preparations. The generation and characterization of A20-/- mice 
have been previously described (20). A20-/-mice were back-crossed for eight 
generations onto a C57BL/6J background. MyD88-/-mice were provided by S. 
Akira (University of Osaka, Osaka, Japan) and R. Medzhitov (Yale University, 
New Haven, CT) and were backcrossed for five generations onto a C57BL/6J 
background before being interbred with A20-/-mice. Chimeric mice were generated 
by reconstitution of lethally irradiated congenic (Ly5.2+) mice with bone marrow 
HSCs. Flow cytometric analyses of tissues from mice were performed with a flow 
cytometer (LSR2; Becton Dickinson) and FlowJo software (Tree Star, Inc.). For 
LPS-induced peritonitis experiments, mice were injected intraperitoneally with 
100μg LPS from  Salmonella typhimurium (Sigma-Aldrich) and sacrificed after 2 h 
for real-time PCR, ELISA, and flow cytometric analyses as described. All animal 
experiments were approved by the Institutional Animal Care and Use Committee 
at the University of California, San Francisco.  
 
BMDMs were generated in DMEM containing 10% FCS and in 10% CMG14-12 
– conditioned media containing MCSF. After 3 d, nonadherent cells were 
aspirated and adherent cells were given fresh MCSF-containing media. After an 
additional 3 d, BMDMs were quantitated and phenotyped by flow cytometry with 
antibodies specific for F4/80 (Serotec) and Mac-1 (BD Biosciences). Macrophage 
purity was typically 90 – 95%. BMDMs were allowed to adhere to tissue culture 
plastic overnight before stimulation.  
 
 
Depletion of commensal intestinal bacteria in chimeric mice. For antibiotic-
mediated depletion of commensal bacteria, chimeric mice were generated by 
transfer of wild-type or A20-/-bone marrow HSCs into sublethally (700 rads) 
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congenic Ly5.2+ C57BL/6J recipient mice. All mice were given trimthoprim-
sulfamethoxazole immediately after reconstitution. 2 wk after reconstitution, some 
mice were given 0.5 grams per liter of vancomycin hydrochloride (Novaplus), 1 
gram per liter of ampicillin (Sandoz), 1 gram per liter of neomycin sulfate (Pharma-
Tek), and 1 gram per liter of metronidazole (Baxter) in drinking water. After 3 – 4 
wk, mice were sacrificed and analyzed by flow cytometry. To quantitate colonic 
microflora, fecal matter was removed from colons, weighed, and homogenized in 
luria broth at 0.1 g/ml before culturing on LB-agar plates.  
 
TLR ligands and ELISAs. LPS from S. typhimurium and poly (I:C) (GE 
Healthcare) were used at concentrations of 1 μ g/ml and 50 ng/ml, respectively. 
BMDMs were stimulated with either LPS or poly (I:C) for 24 h, and culture 
supernatants were assayed by ELISA for IFN-j (PBL Biomedical Laboratories). 
Peritoneal lavages from LPS-stimulated mice were assayed by ELISA for MCP-1 
secretion (BD Biosciences), and sera from these mice were assayed by ELISA for 
soluble IL-15Ra (Duoset; R & D Systems).  
 
RNA isolation and quantitative PCR analyses. RNA was isolated from spleens 
using extraction of homogenized tissue (RNeasy Mini Kit; QIAGEN). RNA was 
treated with Rnase-free DNase (QIAGEN) to eliminate contaminating genomic 
DNA and quantified using a spectrophotometer (ND-1000; Nanodrop). 
Complementary DNA was generated using an RT kit (Quanti-Tect; QIAGEN), and 
real-time quantitative PCR was performed using an SYBR green PCR kit 
(QuantiTect; QIAGEN). The following gene-specific primers were used for 
quantitating  
TNF-α (sense, 5'-TGGCCTCCCTCTCATCAGTT-3'; antisense, 5'-
TCCTCCACTTGGTGGTTTGC-3'), 
IL-1β (sense, 5'-CCGTGGACCTTCCAGGATGA-3'; antisense, 5'-
GGGAACGTCACACACCAGCA-3'), 
IL-10 (sense, 5'-TGAATTCCCTGGGTGAGAAG-3'; antisense, 5'-
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CTCTTCACCTGCTCCACTGC-3'), 
IL-2 (sense, 5'-AAAAGCTTTCAATTGGAAGATGCTG-3'; antisense, 5'-
TTGAGGGCTTGTTGAGATGA-3'), 
IL-13 (sense, 5'-GGAGCTGAGCAACATCACACA-3'; antisense, 5'-
TTGAGGGCTTGTTGAGATGA-3'), 
β-actin (sense, 5'-AAGTGTGACGTTGACATCCGTAA-3'; antisense, 5'-
TGCCTGGGTACATGGTGGTA-3 '), 
MCP-1 (sense, 5'-CCCAATGAGTAGG CTGGAGA-3 '; antisense, 5'-
TCTGGACCCATTCCTTCTTG-3'), 
IFN-β (sense, 5'-CAGCTCCAAGAAAGGACGAAC-3'; antisense, 5'-
GGCAGTGTAACTCTTCTGCAT-3 '), 
and GAPDH (sense, 5'-AACGGGAAGCCCATCACCATCTT-3 '; antisense, 5'-
GCCCTTCCACAATGCCAAAGTT-3 ').  
 
Real-time PCR was performed and analyzed (ABI 7300; Applied Biosystems). 
mRNA relative units (R.U.) were calculated as 2n-(Ct[gene of interest]-Ct[control]), as 
previously described ( 46 ).  
 
Immunoblotting and immunoprecipitations. For in vitro TLR signaling 
experiments, BMDMs were stimulated for the periods of time indicated in the 
figures with 1 μg/ml LPS, washed in PBS, and lysed for 20 min at 4 ° C in RIPA 
lysis buffer (1 × PBS, 20 mM β-glycerophosphate, 1 mM Naorthovanadate, and 
complete protease inhibitor cocktail; Roche) and sonicated. Lysates were cleared 
by centrifugation at 14,000 g for 20 min at 4 ° C, and supernatants were removed 
and boiled in Laemmli buffer for immunoblot analysis of IκBα, phospho-IκBα, or 
phospho-IRF3 (Cell Signaling Technology). For endogenous TRAF6 
immunoprecipitations, 10% SDS was added to cleared lysates for a final 
concentration of 1% SDS and boiled for 5 min. Boiled lysates were diluted 10-fold 
in PBS, and anti-TRAF6 – coupled (Santa Cruz Biotechnology, Inc.) protein A 
beads (Thermo Fisher Scientific) were added. Samples were washed three times 
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with 1 × PBS and boiled in Laemmli buffer for immunoblot analysis with either 
antiubiquitin (P4D1; Santa Cruz Biotechnology, Inc.) or anti-TRAF6 (EMD) 
antibodies. 
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SUMMARY  
 
 A20 is a ubiquitin modifying enzyme that restricts NF-κB signals and 
protects cells against tumor necrosis factor (TNF)-induced programmed cell death. 
Given recent data linking A20 (TNFAIP3) with human B cell lymphomas and 
systemic lupus erythematosus (SLE), we have generated mice bearing a floxed 
allele of Tnfaip3 to interrogate A20ʼs roles in regulating B cell functions. A20-
deficient B cells are hyperresponsive to multiple stimuli and display exaggerated 
NF-kB responses to CD40-induced signals. Mice expressing absent or 
hypomorphic amounts of A20 in B cells possess elevated numbers of germinal 
center B cells, autoantibodies, and glomerular immunoglobulin deposits. A20-
deficient B cells are resistant to Fas-mediated cell death, probably due to 
increased expression of NF-kB-dependent antiapoptotic proteins such as Bcl-x. 
These findings show that A20 can restrict B cell survival, whereas A20 protects 
other cells from TNF-induced cell death. Our studies demonstrate how reduced 
A20 expression predisposes to autoimmunity.  
   
 108 
     
  109 
 
INTRODUCTION  
 
 Maintenance of B-cell homeostasis requires proper intracellular integration 
of signals delivered from multiple surface receptors such as the B cell antigen 
receptor, Toll-like receptors (TLRs), B cell-activating factor (BAFF) receptor, and 
CD40, as well as intracellular cues. Failure to integrate pathways such as NF-κB 
signaling can lead to B cell deficiency, aberrant B cell activity, or even lymphoma. 
Aberrant B cell tolerance and selection can cause production of autoantibodies, 
formation of immune complexes (IC), and ultimately tissue damage and 
autoimmune disease (Fairhurst et al., 2006).   
 Tnfaip3 encodes the A20 protein, a ubiquitin-modifying enzyme (Wertz et 
al., 2004; Boone et al., 2004). A20 was initially identified as a TNF-induced 
molecule that restricts TNF induced signaling (Opipari et al., 1990). Targeting of 
Tnfaip3 in mice revealed A20s critical anti-inflammatory functions, given that A20-
deficient (Tnfaip3-/-) mice exhibit severe spontaneous multiorgan inflammation, 
cachexia, and perinatal death (Lee et al., 2000). Epistasis experiments revealed 
that A20 restricts TLR and nucleosome-binding oligomerization domain (NOD) 
triggered NF-κB signaling, in addition to TNF-induced NF-κB and programmed cell 
death (PCD) signaling (Lee et al., 2000; Boone et al., 2004; Hitotsumatsu et al., 
2008). Thus, A20 restricts a number of innate immune signaling pathways in 
macrophages and fibroblasts. The severe systemic inflammation and cachexia 
caused by A20 deficiency is ameliorated in mice that also lack the TLR adaptor 
protein MyD88 (Turer et al., 2008). Radiation chimeras bearing Tnfaip3-/-
hematopoietic cells also develop spontaneous systemic inflammation, which is 
alleviated by depletion of commensal intestinal bacteria with antibiotics (Turer et 
al., 2008). Thus, A20 maintains immune homeostasis and restricts the potentially 
proinflammatory nature of basal MyD88-dependent signals. 
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 In addition to the innate immune functions described above in 
macrophages and fibroblasts, A20 is also expressed in T and B cells (Sarma et 
al., 1995; Lee et al., 2000).  During T cell activation, A20 is recruited to the MALT-
1-Bcl-10 scaffold complex, and is cleaved by the paracaspase MALT-1 (Coornaert 
et al., 2008).  A20 has also been reported to de-ubiquitinate MALT-1 to restrict 
TCR signals (Duwel et al., 2009).  A20 cleavage is also observed in B lymphoma 
cell lines in response to BCR stimulation (Coornaert et al., 2008).  Other clues that 
A20 may play important roles in adaptive lymphocytes derives from human 
genetic studies that implicate A20 (or TNFAIP3) as a susceptibility gene for 
systemic lupus erythematosus (SLE) – an autoimmune disease associated with 
aberrant B cell function--as well as studies showing that A20 is a tumor 
suppressor gene in B cell lymphomas (Graham et al., 2008; Musone et al., 2008; 
Compagno et al, 2009; Kato et al, 2009; Novak et al, 2009; Schmitz et al, 2009). 
Nevertheless, the physiological roles of A20 in T and B cells are largely undefined. 
 
 B cells are regulated by BCR, TLR, BAFF and CD40 signals. These 
signaling cascades share some of the same ubiquitin-dependent signaling 
molecules utilized by TNF and TLR ligands (e.g., TRAF2, TRAF6, IKKγ) (Hayden 
and Ghosh, 2008).  Given A20ʼs role in preventing inflammation, its genetic 
linkage to human B cell lymphomas and SLE, and the central role B cells play in 
SLE pathogenesis, we hypothesized that A20 may regulate B cell homeostasis 
and prevent autoimmunity. To determine the cell intrinsic functions of A20 in 
regulating B cells, we have generated mice lacking A20 specifically in these cells. 
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RESULTS 
 
 
B-lineage deletion of A20 perturbs lymphoid homeostasis 
 
 In order to analyze the cell intrinsic functions of A20 in B cells, we 
generated a targeting construct in which exon 2 of the Tnfaip3 gene was flanked 
by loxP sites, a “floxed” allele.  The targeting construct was transfected into 
C57BL/6 ES cells and neomycin resistant clones were screened for the targeted 
allele (Figures 1A and B).  Transient transfection of Cre recombinase resulted in 
removal of the neomycin cassette to obtain the floxed Tnfaip3 allele (Figures 1A 
and B).  ES clones were injected into albino C57BL/6 blastocysts, and the 
resultant chimeras were bred with albino C57BL/6 mice.  Non-albino C57BL/6 
progeny were screened for the presence of the floxed allele, Tnfaip3fl (Figure 1B). 
 
 Mice carrying the Tnfaip3fl allele were bred with CD19-Cre knock-in mice to 
generate Tnfaip3+/+, Tnfaip3fl/+ and Tnfaip3fl/fl mice bearing a single copy of the 
Cd19-Cre allele (Rickert et al., 1997).  All mice described in this study were 
heterozygous for the CD19-Cre targeted allele (Cd19-Cre+/-) to control for potential 
nonspecific effects of Cre expression while maintaining CD19 expression.  For 
simplicity, Cd19-Cre+/- mice will subsequently be referred to as Cd19-Cre mice.  
As has been found for other “floxed” alleles, Tnfaip3fl/fl CD19-Cre mice had 
efficient and B cell specific deletion of Tnfaip3 exon 2, as assessed by genomic 
polymerase chain reaction (PCR) and Southern blot (Figure 1C and data not 
shown).  Flow cytometry sorted immature and germinal center (GC) B cells, 
subsets represented in smaller proportions, were also nearly 100% deleted as 
measured by quantitative genomic PCR (Figure 1D).  A20 protein is constitutively 
expressed in B cells and T cells (Figure 1E).  Deletion of Tnfaip3 exon 2 on both 
alleles (Tnfaip3fl/fl CD19-Cre) led to complete loss of A20 protein in splenic B cells 
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(Figure 1E).  Note that deletion of one allele of Tnfaip3 in Tnfaip3fl/+ CD19-Cre 
mice causes hypomorphic (~50%) expression of A20 protein in B cells (Figure 
1E).  
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Figure 1.  Gene targeting strategy to generate mice lacking Tnfaip3 in B 
cells. 
(A) Schematic representation of the gene targeting construct and screening 
strategy for obtaining the Tnfaip3 floxed (fl) allele.  (B) Southern blots of BamHI 
digested genomic DNA from ES cells showing the targeted allele (left blot) and 
from tails from mice with germline inheritance of the fl allele (right blot).  (C) 
Genomic DNA PCR analysis of deletion of Tnfaip3 exon 2 in the indicated cell 
types from mice of the indicated genotypes.  BMDMs are bone marrow derived 
macrophages.  All mice are CD19-Cre+/-.  Sizes of PCR products for floxed (fl), 
wild type (WT) and deleted (Del) alleles are indicated.  Data are representative of 
5 mice per genotype.  (D) Quantitative genomic DNA PCR of flow cyomtery-sorted 
populations from immature (CD19+ CD93[AA4.1]+) and GC (CD19+ GL7+ CD95+) 
B cells from mice of the indicated genotypes.  Error bars show S.E.M. of 3 mice 
per genotype.  (E) Immunoblot analysis of A20 expression in B cells from the 
indicated genotypes of mice.  The A20/actin protein ratio relative to Tnfaip3+/+ 
CD19-Cre cells is shown below the blots.  
 
 Tnfaip3fl/fl CD19-Cre mice were obtained in Mendelian numbers and 
developed normally.   Hence, these mice differed dramatically from mice lacking 
A20 in all cells or in all hematopoietic cells, both of which develop severe 
spontaneous inflammation and early lethality (Lee et al., 2000; Boone et al., 2004; 
Turer et al., 2008).   To begin to assess the roles of A20 in regulating B cells, we 
quantitated lymphoid populations from 5-7 week old Tnfaip3fl/fl CD19-Cre, 
Tnfaip3fl/+ CD19-Cre and Tnfaip3+/+ CD19-Cre littermates by flow cytometry (Table 
1, top panel).  Tnfaip3fl/fl CD19-Cre mice contained moderately increased numbers 
of B cells (CD19+), particularly immature B cells (CD19+IgMhi) and germinal center 
(GC) B cells, when compared to Tnfaip3+/+ CD19-Cre control mice (Table 1, 
Figure 2A, B, C).  Although the percentage of B1a (IgM+, CD5+) cells in the 
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peritoneal cavity of Tnfaip3fl/fl CD19-Cre mice was lower than Tnfaip3+/+ CD19-Cre 
and Tnfaip3fl/+ CD19-Cre mice, the absolute number was not significantly different 
(Figure 2C, S1A, Table 1).   Although A20 deletion in Tnfaip3fl/fl CD19-Cre mice 
occurs in B cells and not T cells (Figure 1C), both B cells (CD19+) and T cells 
(TCRβ+) were modestly expanded in Tnfaip3fl/fl CD19-Cre mice (Figure 2A and 
Table 1).  The relative percentages of T cell subpopulations (CD4+, CD8+, and 
Tregulatory) were normal (data not shown).  Taken together, these findings 
suggest that A20 restricts the numbers of B cells, particularly immature and GC B 
cells. 
 
 Heterozygous Tnfaip3fl/+ CD19-Cre mice possess largely normal numbers 
of lymphoid populations, even though Tnfaip3fl/+ CD19-Cre B cells express half the 
amount of Tnfaip3 protein as wild type Tnfaip3+/+ CD19-Cre B cells (Figure 1E).  A 
notable exception is that the numbers of germinal center (GC) (CD95+GL7+) B 
cells in Tnfaip3fl/+ CD19-Cre mice approximates the number present in Tnfaip3fl/fl 
CD19-Cre mice (Figure 2C and Table 1).  Thus, proper regulation of GC B cell 
homeostasis requires more A20 protein than other B cell populations. 
 
 Bone marrow from Tnfaip3fl/fl CD19-Cre and Tnfaip3fl/+ CD19-Cre mice 
contained normal numbers of B lineage cells, with normal proportions of pro-B 
(CD43+, IgM-) and pre-B (CD43-, IgM-) cells (Figure S1B).  There was a small 
decrease in the percentage of IgM+ B cells in Tnfaip3fl/fl CD19-Cre bone marrow, 
which reflected reductions in mature or re-circulating (IgM+, IgD+) B cells (Figure 
S1B).  As CD19 is expressed throughout B cell development, these results 
suggest that A20 is not required for early B cell differentiation. 
 
 The differences in peripheral lymphocyte populations described above 
persisted but were not further exaggerated in 6 month old mice (Figure S1C and 
data not shown).  In addition, six month old Tnfaip3fl/+ CD19-Cre and Tnfaip3fl/fl 
CD19-Cre mice contained increased percentages of splenic plasma cells when 
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compared to Tnfaip3+/+ CD19-Cre mice (Figure 2D).  While markers of B cell 
activation were expressed normally in 5-7 week old mice, spontaneous B cell 
activation became apparent in 6 month old Tnfaip3fl/fl CD19-Cre but not Tnfaip3fl/+ 
CD19-Cre mice (Figure 2E, S1D).  Spontaneous T cell activation was not 
observed (data not shown).  These findings suggest that A20 expression in B cells 
prevents spontaneous activation and differentiation of B cells over time. 
 
 Overall, elevated numbers of T and B cells and spontaneous B cell 
activation were observed in Tnfaip3fl/fl CD19-Cre mice by six months of age.  In 
addition, elevated numbers of GC B cells were observed in both heterozygous 
Tnfaip3fl/+ CD19-Cre mice and homozygous Tnfaip3fl/fl CD19-Cre mice. 
 
Figure 2.  Flow cytometric analyses of B lymphocyte populations in 
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Tnfaip3fl/fl CD19-Cre mice. 
Flow cytometric analyses of lymphoid tissues.  (A) Analyses of lymphoid 
populations in spleens and peripheral lymph nodes from 5 - 7 week-old mice.  (B) 
Analysis of CD19+ gated cells showing B-cell maturation (IgM, IgD) from 5 - 7 
week-old mice..  (C) Analysis of CD19+ gated cells showing GC B cells (GL7+ 
CD95+) from 5 - 7 week-old mice.   (D) Plasma cells (CD19+ low CD138+) within 
TCRβ- CD19+ gated splenic B cells from 6 month old mice are shown. 
Percentages of cells within the indicated gates are shown on plots.  E) Histograms 
comparing expression of B cell activation markers (CD80, CD69, and CD95) on 
CD19+ gated cells from Tnfaip3+/+ cells (shaded histogram) Tnfaip3fl/+ cells (blue 
line) and Tnfaip3fl/fl B cells (red line).   All data compare littermates of the indicated 
genotypes and are representative of 3-5 mice per genotype. 
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Figure S1. 
Flow cytometric analyses of B cells from lymphoid organs of Tnfaip3+/+, 
Peripheral
lymph nodes
CD80
CD40
Spleen
IAb
CD95
Figure S 1
P
e
ri
to
n
e
a
l 
c
a
v
it
y
C
D
5
fl/+ fl/fl+/+
26.7
71.6
19.8
78.5
9.1
89.3
IgM
Ig
M
CD43
B
o
n
e
 m
a
rr
o
w
fl/+ fl/fl+/+
IgM
20.5
54.9 21.1
18.5
56.3 21.9
16.2
59.1 21.4
Ig
D
14
6.3
13.1
5.0
12
2.9
GL7
C
D
9
5
 
fl/+ fl/fl
IgM
Ig
D
+/+
2.52 13.1
11.3
66.2
3.06 17.5
9.73
63.4
6.46 23.3
9.85
53.4
0.36 1.13 0.7 S
p
le
e
n
A
C
B
D
 118 
Tnfaip3fl/+, and Tnfaip3fl/fl mice.  (A) Peritoneal cells from 5 to 7 week old mice 
were lymphocyte gated and analyzed  for the percentages of B1a (IgM+ CD5+) and 
B2 (IgM+ CD5-) cells.   (B) Bone marrow cells from 5 to 7 week old mice were 
lymphocyte gated and analyzed for the percentages of B cells at various 
differentiation stages.  (C) Spleen cells from 6 month old mice were gated on 
CD19+ cells and analyzed for B cell maturation stages (IgM, IgD) and GC B cells 
(GL7+ CD95+).  Numbers in the plots represent the percentages of B cells of the 
demarcated subsets (A-C).  (D) Spleens and lymph nodes from 5 to7 week old 
mice were gated on CD19+ and analyzed for expression of the indicated surface 
activation markers: Tnfaip3+/+ (shaded histogram), Tnfaip3fl/+ (blue line), and 
Tnfaip3fl/fl (red line).  
 
 
Table 1.  Cellularity of lymphoid organs and respective subpopulations in 
Table 1. Cellulariry of B lymphocytes populations in Tnfaip3+/+, Tnfaip3fl/+ and Tnfaip3fl/fl CD19-Cre mice
Lymph Nodes
Spleen
Bone Marrow
Peritoneum
B-cells 4.7 0.5 8.8 1.1
T-cell 8.4 0.8 12.9 1.6
Myeloid Cells 0.15 0.03 0.24 0.03
Mature B-cells
Immature B-cells
B-cells 26.5 4.5 37.8 6.4
T-cell 16.1 1.7 24.7 2.5
Myeloid Cells 1.0 0.2 1.4 0.3
Mature B-cells 15.1 3.6
14.8 2.6Immature B-cells 9.2 0.7
17.9 3.1
 ±
 ±
 ±
 ±
 ±
 ±
 ±
 ±
 ±
 ±
 ±
 ±
 ±
 ±
 ±
 ±
 ±
 ±
 ±
 ±
 ±
 ±
 ±
 ±
 ±
 ±
 ±
14.3 0.7
44.4 11
3.2
4.7 0.7
 ±
 ±
 ±
 ±
15.8 1.2 25.7 3.7
55.4 9.0 74.2 11
30.7 5.6 31.2 4.1
3.8 1.1 8.1 1.6
3.9 0.2
8.9 0.7
0.15 0.03
2.5 0.1
1.2 0.1
 ±
 ±
 ±
 ±
 ±
2.9 0.3 3.3 0.5
1.1 0.2 3.9 0.3
Marginal Zone B-cells 1.6 0.08 1.1 0.3 0.9 0.2
 ±
 ±
 ±
 ±
 ±
 ±  ±  ±
23.7 6.0
16.5 0.8
0.7 0.03
11.2 1.4
9.8 0.6
Germinal Center B-cells 0.17  ±  ±  ±0.03 0.6 0.15 0.45 0.08
Germinal Center B-cells 0.01  ± 0.003 0.08  ± 0.02 0.05  ± 0.02
31.4
 ±
B-cells
B1a
B2 0.55  ±  ±  ±0.16 0.93 0.11 1.6 0.12
0.45 0.04 0.69 0.16 0.6 0.24 ±  ±  ±
1.6  ±  ±  ±0.34 2.7 0.25 4.1 0.37
*
*
*
*
*
*
*
*
*
*
Total cellularity  (x106)
Spleen  (x106)
Lymph Nodes  (x106)
Peritoneum  (x106)
+/+ "/+ "/"
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Tnfaip3fl CD19-Cre mice. 
Quantitation of lymphoid populations in the indicated tissues from the indicated 
genotypes of 5-7 week old mice.  The total cellularity of lymphoid organs is shown 
in the top panel.  Subpopulations were identified by flow cytometry using the 
indicated markers: B cells (CD19+); T-cells (TCRβ+); myeloid cells (Mac-1+); 
mature B-cells (CD19+, IgMLo, IgD+); immature B-cells (CD19+ IgMhi); marginal 
zone B-cells (CD21/35Hi CD23Lo); GC B cells (CD19+, GL7+, CD95+); B1a (IgM+, 
CD5+).  * indicates significant difference relative to +/+ (p < 0.05, using one-way 
Anova).  For GC B-cells, means are from 5 mice per genotype; for all other 
subpopulations, means of 5 Tnfaip3+/+ CD19-Cre, 11 Tnfaip3fl/+ CD19-Cre and 11 
Tnfaip3fl/fl CD19-Cre mice are shown. 
 
 
Exaggerated responses of Tnfaip3fl/fl CD19-Cre B cells in vitro.  
 
 Our prior work indicated that A20 restricts TNF, TLR, and NOD induced 
NF-kB signals as well as TNF induced PCD in fibroblasts and macrophages (Lee 
et al., 2000; Boone et al., 2004; Hitotsumatsu et al., 2008; Turer et al., 2008).  B 
cells receive activation, proliferation and survival signals from BCR, CD40 
receptor, and other receptors (Skaug et al., 2009).  To test if A20 directly regulates 
B cell responses, we assayed responses of Tnfaip3fl/fl CD19-Cre, Tnfaip3fl/+ CD19-
Cre and Tnfaip3+/+ CD19-Cre splenic B cells to LPS, cytosine phosphoguanine 
oligodeoxynucleotide (CpG) and to agonist anti-IgM and anti-CD40.   As noted 
above, unstimulated splenic B cells from young (5-7 week old) Tnfaip3fl/fl CD19-
Cre mice resembled B cells from Tnfaip3fl/+ CD19-Cre and Tnfaip3+/+ CD19-Cre 
mice (Supplementary Figure 1).  Tnfaip3fl/fl CD19-Cre B cells expressed higher 
levels of CD80 (B7.1) and CD69 after stimulation with several B cell agonists 
(Figure 3A and data not shown).  Tnfaip3fl/fl CD19-Cre B cells also proliferated to a 
greater extent than control cells (Figure 3B).  Thirdly, Tnfaip3fl/fl CD19-Cre B cells 
produced more IL-6 than Tnfaip3fl/+ CD19-Cre and Tnfaip3+/+ CD19-Cre cells after 
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treatment with LPS and CpG (Figure 3C). 
 
 To control for potential differences in B cell populations and to avoid 
potential caveats associated with developmental abnormalities, we sought to 
eliminate A20 expression in mature B cells after B cell development.  Accordingly, 
we interbred Tnfaip3fl mice with estrogen receptor (ER)-Cre [Gt(ROSA)26ER-Cre] 
mice to obtain mice in which A20 (Tnfaip3) deletion would not occur until cells 
were exposed to 4-hydroxytamoxifen (4-OH-T).   Splenic B cells enriched from 
Tnfaip3fl/fl ER-Cre mice and treated with 4-OH-T in vitro effectively ablated A20 
protein expression (Figure 3D).  We then tested responses of these B cells.  
Consistent with our findings with Tnfaip3fl/fl CD19-Cre B cells, mature splenic 
Tnfaip3fl/fl ER-Cre B cells rendered acutely A20 deficient with 4-OH-T exhibited 
exaggerated responses to all receptor stimuli when compared to control Tnfaip3fl/+ 
ER-Cre cells (Figure 3E).  Thus, A20 expression in mature B cells restricts B cell 
responses independently of any potential roles of A20 in regulating B cell 
development. 
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Figure 3.  Hyper-responsiveness of A20-deficient B cells. 
In vitro responses of purified B cells after stimulation with the indicated stimuli for 
72h.  Flow cytometric analyses of (A) surface expression of the activation marker 
CD80 (B7.1) and (B) dilution of CFSE-labeled cells.  Tnfaip3fl/fl CD19-Cre cells are 
shown in red lines; Tnfaip3fl/+ CD19-Cre cells shown in blue lines; and Tnfaip3+/+ 
CD19-Cre cells shown in shaded gray histograms.  (C) ELISA determination of IL-
6 secretion in the supernatants of 72 hr B cell cultures.  Means and standard 
deviations of triplicate wells are shown.  (D) Immunoblots of A20 and actin protein 
expression in purified Rosa-ER-Cre+ B cells of the indicated genotypes.  Lysates 
were isolated after 72 hr stimulation with the indicated ligands in the presence of 
4-OH-T.  (E) Expression of CD80 in purified B cells after treatment with 4-OH-T 
and the indicated ligands for 72hr.  Tnfaip3fl/fl GT-Rosa-Cre+ B cells treated with 
IL-4 or media (black lines) or the indicated ligands (red lines); Tnfaip3fl/+ GT-Rosa-
Cre+ B cells treated with IL-4 or media (gray shaded histograms) or the indicated 
ligands (blue lines).  All data are representative of 3 independent experiments. 
 
 
A20 restricts NF-kB activation signals downstream of CD40. 
 
 A20 restricts cellular responses to TNF, TLR, and NOD2 ligands by 
restricting NF-kB signaling (Lee et al., 2000; Boone et al., 2004; Hitotsumatsu et 
al., 2008; Turer et al., 2008).  CD40 is a tumor necrosis factor receptor (TNFR) 
family member that triggers NF-κB signals and supports B cell activation and 
survival (Elgueta et al., 2009).  To test whether A20 directly restricts CD40 
induced NF-kB signals, splenic B cells from Tnfaip3+/+ CD19-Cre and Tnfaip3fl/fl 
CD19-Cre mice were stimulated with agonist anti-CD40 antibody.  A20 protein 
was dramatically induced by CD40 engagement in Tnfaip3+/+ CD19-Cre B cells, 
whereas no A20 expression was observed in Tnfaip3fl/fl CD19-Cre B cells (Figure 
4A).  Tnfaip3fl/fl CD19-Cre B cells displayed increased and prolonged canonical 
NF-kB signaling as measured by IkBα phosphorylation in response to anti-CD40 
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(Figure 4B).  Agonist anti-CD40 also induced greater levels of phospho-p100, an 
indicator of non-canonical NF-κB signaling, in Tnfaip3fl/fl CD19-Cre B cells when 
compared to Tnfaip3+/+ CD19-Cre B cells (Figure 4C).  This increased non-
canonical NF-κB signaling correlates with increased basal p100 protein levels in 
Tnfaip3fl/fl CD19-Cre B cells (Figure 4C).  By contrast, Erk phosphorylation was 
similarly induced in Tnfaip3fl/fl CD19-Cre and control B cells (Figure 4D).  
 
 
Figure 4.  A20 restricts NF-κB signaling downstream of CD40 signals. 
(A) Immunoblot analysis of A20 protein induction by agonist anti-CD40.  (B) 
Immunoblot analyses of phospho-IκBα and IκBα after CD40 stimulation. Ratios of 
pIkBα/IkBα were normalized to time 0 of Tnfaip3+/+ CD19-Cre cells and are shown 
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below. (C) Immunoblot analyses of NF-κB P-p100 (upper panel) and p100 (middle 
panel) protein levels in response to agonist anti-CD40 antibody.  Ratios of P-
p100/actin, normalized to time 0 sample in Tnfaip3+/+ CD19-Cre B cells, are 
shown below P-p100 immunoblot.  Ratios of p100/actin, normalized to time 0 
sample in Tnfaip3+/+ CD19-Cre B cells, are shown below p100 immunoblot.  (D) 
Immunoblot analysis of Erk signaling.  Ratios of pErk/Erk were normalized to time 
0 of Tnfaip3+/+ CD19-Cre cells and are shown below.  Actin protein levels shown 
below all panels as loading controls.  Data are representative of 3 independent 
experiments. 
 
 
Normal antigen specific B cell responses in Tnfaip3fl/fl CD19-Cre mice. 
 
 A20ʼs capacity to restrict B cell activation in vitro suggests that Tnfaip3fl/fl 
CD19-Cre mice might exhibit exaggerated antigen specific B cell responses in 
vivo.  We thus tested antigen specific B cell responses to NP-KLH in these mice.  
At baseline, Tnfaip3fl/fl CD19-Cre mice have more IgM and modestly elevated 
amounts of IgGs (Figure S2A).  Tnfaip3fl/fl CD19-Cre mice produced 
proportionately higher amount of anti-NP IgM antibodies before and after 
immunization with NP-KLH (Figure S2B).  Anti-NP IgG levels were similar in the 
various genotypes of mice (Figure S2C).  Thus, T cell dependent B cell responses 
occur largely normally in Tnfaip3fl/fl CD19-Cre mice.  Anti-NP-Ficoll IgM responses 
paralleled T cell dependent NP-KLH responses in Tnfaip3fl/fl CD19-Cre mice, 
indicating that T cell independent B cell responses also occur normally in these 
mice (data not shown). 
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Figure S2. 
Normal antigen specific B cell responses in Tnfaip3fl/fl CD19-Cre mice. 
ELISA analyses of serum immunoglobulin amounts from Tnfaip3+/+, Tnfaip3fl/+, 
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and Tnfaip3fl/fl mice.  (A) Ig isotypes levels in unimmunized 5 to 7 week-old mice 
(n=6) plotted as means ± SEM.  * indicates p < 0.05 by one-way ANOVA.  (B) T-
cell dependent, antigen specific B cell responses to NP-KLH.  NP-specific 
antibody amounts before and after immunization at the indicated time points were 
plotted as the geometric mean ± SEM of 5 mice.  Serum dilutions of 1:200 for IgM 
and 1:100 for IgG1 and IgG2b are shown.  * indicates p < 0.05 by two-way 
ANOVA. 
 
 
Tnfaip3fl/fl CD19-Cre and Tnfaip3fl/+ Cd19-Cre mice develop autoimmunity.  
 
 Increased numbers of immature and germinal center B cells suggest that 
auto-reactive B cells may accumulate and produce autoantibodies in Tnfaip3fl/fl 
CD19-cre mice.  In addition, several SNPs near the human A20 (Tnfaip3) gene 
are independently associated with susceptibility to SLE (Graham et al., 2008; 
Musone et al., 2008).  To characterize the autoantibody profile of Tnfaip3fl/+ CD19-
Cre mice and Tnfaip3fl/fl CD19-Cre mice as compared to Tnfaip3+/+ CD19-Cre 
mice, we used large-scale 1152-feature protein and peptide microarrays to detect 
autoantibodies directed against over 140 antigens (Robinson et al., 2002).  
Antibodies to over 46 self antigens were detected, including antibodies to nuclear 
antigens (e.g., single stranded DNA, small ribonuclear proteins A and C, Ku 
protein), glomerular antigens (e.g., vimentin, collagen X, proteogylcan, and 
aggrecan), and heat shock proteins (Figure 5A).   Importantly, the serum 
autoantibody profiles from Tnfaip3fl/fl CD19-Cre and Tnfaip3fl/+ CD19-Cre mice 
clustered well with each other and away from Tnfaip3+/+ CD19-Cre mice (Figure 
5A).  These autoantibodies were observed in both male and female mice and 
were observed in C57BL/6 inbred mice, a strain that is relatively resistant to SLE-
like disease.  Elispot analysis for anti-DNA indicate both an increase in the 
number and size of anti-DNA producing B cells in Tnfaip3fl/fl CD19-Cre mice 
(Figure 5B and data not shown).  These findings indicate that A20 expression in B 
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cells prevents spontaneous production of autoantibodies.   
 
 Autoantibodies can be deposited in glomeruli of kidneys of SLE patients 
and ultimately cause glomerulonephritis.  To determine whether serum 
autoantibodies in Tnfaip3fl/fl CD19-Cre and Tnfaip3fl/+ CD19-Cre mice lead to 
glomerular Ig deposits, we examined kidneys from 6 month old mice by histology 
and immunofluorescence.  Although kidney sections appeared histologically 
normal, IgM deposits were observed in the kidneys of both Tnfaip3fl/fl CD19-Cre 
and Tnfaip3fl/+ CD19-Cre mice (Figure 5C).  IgG deposits were more prominent in 
Tnfaip3fl/+ CD19-Cre mice (Figure 5C). 
 
 In addition to autoantibody producing B cells “escaping” from negative 
selection, activation of innate immune cells and type I interferon (IFN I) secretion 
may be key factors contributing to autoantibody production and the pathogenesis 
of SLE (Fairhurst et al., 2006; Shlomchik, 2008).  CpG triggers B cell activation 
and production of type I interferons (IFN), and increases class switching to 
pathogenic autoantibody isotypes (Ehlers et al., 2006).  We thus asked whether 
Tnfaip3fl/+ CD19-Cre and Tnfaip3fl/fl CD19-Cre mice develop more autoimmune 
disease after stimulation with CpG.  CpG treatment of intact mice enhanced 
production of IgG anti-dsDNA antibodies in serum as well as pathogenic 
deposition of IgG in renal glomeruli of both Tnfaip3fl/fl CD19-Cre and Tnfaip3fl/+ 
CD19-Cre mice but not Tnfaip3+/+ CD19-Cre mice (Figure 5D and data not 
shown).  Taken together, these findings indicate that A20 expression in B cells 
prevents autoimmunity. 
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Figure 5.  Spontaneous autoantibody production in Tnfaip3fl/+ CD19-Cre and 
Tnfaip3fl/fl CD19-Cre mice. 
(A) Protein array analyses of autoantibodies in sera from 3 month old Tnfaip3fl/fl 
CD19-Cre (n=5), Tnfaip3fl/+ CD19-Cre (n=3), and Tnfaip3+/+ CD19-Cre (n=4) mice. 
Heat map shows relative reactivity to the respective antigens on the arrays, 
hierarchically clustered in both axes by Euclidean Distance.  The reactivity 
intensities (MFI) are depicted on a relative color scale.  Statistically different 
antigens were identified using 2-class SAM with an unpaired t-test.  (B) Antibody 
Forming Cells (AFC) measured on an Elispot for anti-dsDNA Ig producing B-cells. 
Counts were plotted as the mean of triplicate wells and S.D. is shown. Data are 
representative of 3 independent experiments.  (C) Immunofluorescent analyses of 
glomerular Ig deposition in 6 month old mice of indicated genotypes.  Analyses of 
IgM and IgG deposits shown in upper and middle panels, respectively.  Data are 
representative of at 3 mice per genotype.  Sections stained with hematoxylin and 
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eosin are shown above.  (D) Immunofluorescent analyses of glomerular deposition 
of Igs of the indicated isotypes after CpG treatment. 8-10 week old mice (n=4) of 
the indicated genotypes were treated with 40 μg of CpG intraperitoneally every 
other day for 2 weeks.  Mice were analyzed 6 weeks after start of treatment.  H&E 
sections shown above.  All sections 100X magnification. 
 
 
A20 restricts B cell survival to Fas-mediated PCD. 
 
 Tnfaip3fl/+ CD19-Cre mice share two key features with Tnfaip3fl/fl CD19-Cre 
mice: increased numbers of GC B cells and susceptibility to autoimmunity.  These 
observations suggest that A20 expression levels may regulate B cell selection in 
germinal centers.  One possible mechanism for negative selection of autoreactive 
B cells in GCs is Fas-induced PCD (Hao et al., 2008).  We thus tested the 
susceptibility of Tnfaip3+/+ CD19-Cre, Tnfaip3fl/+ CD19-Cre, and Tnfaip3fl/fl CD19-
Cre B cells to Fas-induced PCD.  Splenic B cells were activated with agonist anti-
CD40 to induce Fas sensitivity.  As expected, activation of Tnfaip3+/+ CD19-Cre B 
cells caused increased expression of Fas and dose dependent sensitivity to Fas 
mediated PCD (Figure 6A, B).  Tnfaip3fl/fl CD19-Cre B cells expressed higher 
levels of Fas than Tnfaip3+/+ CD19-Cre B cells after CD40 stimulation, while 
Tnfaip3fl/+ CD19-Cre B cells expressed intermediate levels (Figure 6A).  
Remarkably, Tnfaip3fl/fl CD19-Cre and Tnfaip3fl/+ CD19-Cre B cells were resistant 
to Fas-mediated PCD when compared to control Tnfaip3+/+ CD19-Cre cells--even 
though Tnfaip3fl/fl CD19-Cre and Tnfaip3fl/+ CD19-Cre B cells expressed greater 
amounts of Fas (Figure 6B).   This finding is particularly surprising given our prior 
observation that Tnfaip3-/- fibroblasts are more susceptible to TNF induced PCD 
than Tnfaip3+/+ cells (Lee et al, 2000).  Thus, A20 supports Fas mediated PCD in 
B cells while inhibiting TNFR induced PCD in fibroblasts. 
 
 To understand why A20 deficient B cells are resistant to Fas mediated 
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PCD, we hypothesized that increased NF-kB signaling in these cells might lead to 
increased expression of anti-apoptotic proteins such as Bcl-x.  After stimulation 
with agonist anti-CD40 in vitro, Bcl-x mRNA levels increased within one hour, and 
rose to a higher level in Tnfaip3fl/fl CD19-Cre B cells compared with Tnfaip3fl/+ 
CD19-Cre or Tnfaip3+/+ CD19-Cre B cells (Figure 6C).  CD40 triggered induction 
of Bcl-x mRNA was blocked by the NF-kB inhibitor, NEMO-binding domain (NBD) 
peptide, but not by control peptide (Figure 6C).  Hence, NF-kB signaling appears 
directly required for induced Bcl-x mRNA transcription.  Consistent with enhanced 
Bcl-x mRNA expression, markedly higher levels of Bcl-x protein appear in 
Tnfaip3fl/fl CD19-Cre B cells compared with Tnfaip3fl/+ CD19-Cre or Tnfaip3+/+ 
CD19-Cre B cells (Figure 6D).  Taken together, these findings indicate that A20 
restricts the survival of activated B cells by limiting the NF-kB dependent 
transcription of Bcl-x mRNA and the subsequent production of Bcl-x protein.  They 
also provide a potential mechanism by which A20 deficient B cells are resistant to 
negative selection in germinal centers. 
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Figure 6.  A20 deficient and hypomorphic B-cells are resistant to 
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programmed cell death. 
(A) Flow cytometric analysis of CD95 (Fas) expression in enriched B cells after 
agonist anti-CD40  stimulation.  Overlays of CD95 histograms on gated CD19+ 
cells from Tnfaip3+/+ CD19-Cre (shaded), Tnfaip3fl/+ CD19-Cre (dashed line), 
Tnfaip3fl/fl CD19-Cre (black line), and unstained control (dotted line) are shown.  
(B) Enriched B-cells stimulated for 48 hours with agonist anti-CD40 and treated 
with the indicated concentrations of agonist anti-CD95 for 12 hours were analyzed 
for survival by measuring the percentage of dead (Annexin-V+ DAPI+) cells by flow 
cytometry.  Percent death was calculated as [% Fas induced dead -  % control 
dead / 100% - % control dead].  Data are plotted as mean ± S.D of triplicate wells.  
* indicates p < 0.001 using two way Anova.  (C) Bcl-x mRNA levels measured by 
real time quantitative (RT qPCR) in enriched B-cells. Cells of the indicated 
genotypes were stimulated with agonist anti-CD40 for the indicated times in the 
presence of an inhibitor or a control peptide, or left unstimulated.  (D) Immunoblot 
analysis for the expression of Bcl-x protein in B-cells of the indicated genotypes 
stimulated with agonist anti-CD40 for the indicated times.  Actin protein levels are 
shown below as control.   Ratios of Bcl-x to actin protein, normalized to the 
Tnfaip3+/+ B cells at time 0, are shown below each sample.  All data are 
representative of 3 independent experiments. 
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DISCUSSION 
 
 
 
 The generation and characterization of mice lacking A20 specifically in B 
cells, Tnfaip3fl/fl CD19-Cre mice, has allowed us to unveil several novel functions 
for A20.  We have discovered that B cell specific expression of A20 restricts CD40 
and BCR responses, terminates CD40 triggered NF-kB signals, restricts B cell 
survival, and prevents autoimmunity.  These studies provide unique molecular 
insights into B cell homeostasis, human SLE and B cell lymphomas. 
 
 Tnfaip3fl/fl CD19-Cre mice are largely healthy, in marked contrast to mice 
lacking A20 expression in all cells or in all hematopoietic cells.  This observation is 
consistent with our prior suggestion that the cachexia, myeloid dysregulation and 
perinatal lethality observed in globally deficient A20 mice is primarily due to 
myeloid cell dysfunction.  Like other “floxed” alleles bred to CD19-Cre mice, 
Tnfaip3fl/fl CD19-Cre mice delete A20 in a highly B cell-specific fashion.  While 
these mice contained mild expansion of T cell numbers, these perturbations are 
probably not due to aberrant A20 deletion as judged by our molecular analyses 
and by the published literature for this Cre strain (Rickert et al., 1997; Schmidt-
Supprian and Rajewsky, 2007).  Although Tnfaip3fl/fl CD19-Cre mice did not 
express measurable serum levels of IL-6 or IL-4 by ELISA, they did express 
increased levels of splenic IL-4 mRNA (data not shown); and Tnfaip3fl/fl CD19-Cre 
B cells produced more IL-6 and expressed higher levels of co-stimulatory 
molecules upon stimulation.  Thus, T cell expansion may be due to antigen-
independent bystander effects induced by B cell derived cytokines and/or co-
stimulatory molecules, as has previously been observed in other settings of B cell 
hyper-responsiveness (Homig-Holzel et al., 2008; Hao et al., 2008).   
 
 Our findings demonstrate that A20 performs important functions in adaptive 
immune cells in addition to previously described functions in innate immune cells 
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(Lee et al, 2000; Boone et al, 2004; Hitotsumatsu et al, 2008).  A20ʼs roles in 
restricting CD40 and BCR triggered NF-kB signals add to the spectrum of 
signaling cascades regulated by this ubiquitin modifying enzyme.  NF-kB signaling 
is known to be important for regulating B cell homeostasis (Sen 2006; Siebenlist et 
al, 2005).  The phenotypes of our mice lacking A20 expression in B cells reveal 
the importance of tightly regulating basal NF-kB signals in these cells. 
 
 B cell specific loss of A20 expression leads to increased numbers of 
autoantibody producing cells.  B cells undergo several stages of negative 
selection to eliminate autoreactive cells both in the bone marrow and in peripheral 
lymphoid organs (Jacobi and Diamond, 2005; Shlomchik, 2008; Yurasov and 
Nussenzweig, 2007; von Boehmer and Melchers, 2010).  In the bone marrow, 
immature B cells are selected as a consequence of BCR and BAFF signals, and 
intracellular cell survival factors.  In the periphery, selection occurs during GC 
maturation.  Germinal centers are sites where B cells undergo expansion, 
immunoglobulin class switching, somatic hypermutation, and affinity maturation 
(Klein and Dalla-Favera, 2008).   B cells with low affinity for antigen or reactivity 
for self antigens are negatively selected within GCs (Shlomchik, 2008).  Deletion 
of autoreactive B cells helps prevent autoimmunity, and defective GC selection of 
autoreactive B cells has been observed in human SLE patients (Cappione et al., 
2005).  Fas (CD95) is highly expressed on GC B cells (Watanabe et al, 1995).  
While the role of Fas mediated PCD in GC selection has been controversial (Smith 
et al., 1995; Takahashi et al., 2001; Mizuno et al., 2003; Hoa et al., 2008), Fas 
mediated PCD likely plays an important role in eliminating autoreactive B cells  
(Rathmell et al., 1995; Fukuyama et alk., 2002; William et al., 2002).  Thus, the 
accumulation of GC B cells in Tnfaip3fl/+ CD19-Cre and Tnfaip3fl/fl CD19-Cre mice 
may be due to the increased resistance of A20 deficient B cells to physiological 
PCD, leading to the escape of autoreactive B cells.  
 
 How might A20 deficiency in B cells render them resistant to PCD?  One 
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possibility stems from the observation that NF-kB dependent proteins protect B 
cells against PCD.  Indeed, both canonical and non-canonical NF-kB signaling 
downstream of BCR, CD40, BAFF, and TLR receptors are thought to promote B 
cell survival as well as proliferation and activation (Siebenlist et al., 2005; Sen, 
2006; Homig-Holzel et al., 2008).  NF-kB has been suggested to be necessary for 
mediating BCR induced resistance to Fas mediated PCD (Mizuno and Rothstein, 
2003; Schram and Rothstein, 2003).  Our studies indicate that A20 directly 
restricts canonical NF-kB signals and suggest that these signals may lead to 
elevated non-canonical NF-kB signals.  These increased NF-kB signals lead to 
increased expression of anti-apoptotic proteins such as Bcl-2 and Bcl-x.  
Deregulated expression of these proteins has been shown to cause altered GC B 
cell selection (Grillot et al., 1996; Takahashi et al., 1999).  Hence, increased 
expression of Bcl-x and/or other NF-kB dependent proteins may provide a 
molecular underpinning for increased numbers of GC B cells in Tnfaip3fl/fl CD19-
Cre mice.   
 
 Heterozygous Tnfaip3fl/+ CD19-Cre mice contain similarly increased 
numbers of GC B cells and autoantibodies as homozygous Tnfaip3fl/fl CD19-Cre 
mice at young ages (i.e., 5-7 weeks old), suggesting that a high threshold level of 
A20 expression must be maintained for properly selecting (or deleting) these cells.  
Reduced A20 expression in other cell types leads to increased production of NF-
kB dependent gene products, so endogenous levels of A20 expression appear to 
be limiting (O. Hitotsumatsu , S. Oshima, G. Hammer, unpublished data).  
Reduced (rather than absent) levels of A20 expression or hypomorphic A20 
proteins may also link A20 (Tnfaip3) susceptibility SNPs with SLE in human 
patients (Musone et al, 2008).  Thus, mice expressing reduced levels of A20 may 
prove to be highly relevant models of human autoimmune diseases. 
 
 While reduced A20 expression in B cells leads to accumulation of GC B 
cells and IgG autoantibodies, absent A20 expression also causes accumulation of 
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immature B cells and IgM in Tnfaip3fl/fl CD19-Cre mice and progressive activation 
of B cells with age.  Hence, a lower amount of A20 is necessary to preserve 
selection of immature B cells and to restrict spontaneous B cell activation than the 
amount required for proper GC selection.  As IgM autoantibodies may be 
protective against IgG mediated autoimmune disease, higher IgM levels in 
homozygous Tnfaip3fl/fl CD19-Cre mice may reduce the degree of autoimmune 
disease observed in these mice (Witte, 2008).  A20 levels are dynamically 
regulated, largely in response to NF-kB signals (Krikos et al, 1992).  Thus, A20 
expression levels appear to be finely tuned to regulate NF-kB signaling and 
survival of distinct subsets of B cells.   
 
 Tnfaip3fl/fl CD19-Cre mice exhibit largely normal antigen specific B cell 
responses in vivo, despite the fact that mature Tnfaip3fl/fl CD19-Cre B cells exhibit 
increased responses to BCR, CD40, and TLR ligands in vitro. These findings 
suggest that B cell independent factors such as T cells and myeloid cells can 
properly restrict antigen specific B cell responses, even if they allow progressive 
accumulation of autoreactive B cells in Tnfaip3fl/fl CD19-Cre mice.   
 
 Our experiments indicate that A20 expression in B cells regulates GC B cell 
selection as well as B cell activation, thereby regulating key aspects of B cell 
tolerance.  It is remarkable that B cell specific deletion of A20 alone is sufficient for 
autoimmunity in C57BL/6 mice.  The appearance of IgG deposits suggests that 
abnormal B cells are sufficient for at least the initial stages of the autoimmunity 
and are part of the continuum to full blown disease.  Hence, lupus prone Tnfaip3fl/fl 
CD19-Cre and Tnfaip3fl/+ CD19-Cre mice as well as genetic derivatives of these 
mice should be useful models for understanding human SLE.  Heterozygous 
Tnfaip3fl/+ CD19-Cre mice may be particularly relevant, as reduced, rather than 
absent A20 expression may characterize this human condition. 
 
 Recent studies have shown that somatic loss of A20 in B cells causes 
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several types of Hodgkin, non-Hodgkin, and marginal zone B cell lymphomas in 
humans (Kato et al., 2009; Compagno et al., 2009; Schmitz et al., 2009; Novak et 
al., 2009).  Our findings that A20 deficient B cells express high levels of Bcl-x and 
are resistant to Fas mediated PCD provide molecular insights into how A20 
functions as a tumor suppressor in B cells.  Remarkably, A20 is a pro-apoptotic 
protein in B cells even though it restricts TNF induced apoptosis in fibroblasts and 
hepatocytes (Lee et al., 2000; Arvelo et al., 2002).  Hence, it is critical to analyze 
A20ʼs physiological functions in cell type-specific contexts.   Future studies testing 
the potential of A20 deficiency to collaborate with other B cell oncogenes may 
reveal the spectrum of A20ʼs tumor suppressor functions in B cells. 
 
 In conclusion, we have demonstrated functions for A20 in regulating B cell 
responses, including the restriction of CD40 induced NF-kB signals.  These cell 
autonomous functions are critical for B cell homeostasis and the prevention of 
autoreactive B cells and autoimmunity.  In addition to unveiling new molecular 
mechanisms of B cell homeostasis, these studies provide critical insights into the 
pathogenesis of human SLE and B cell lymphomas. 
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METHODS 
 
 
 
Generation of A20 conditionally targeted (Tnfaip3fl/fl) mice.  
 
Recombineering was used to generate a gene targeting construct from a bacterial 
artificial chromosome (BAC) from the C57BL/6J strain containing the Tnfaip3 
gene. C57BL/6 ES cells (PRX-B6T, Primogenix) were transfected with this 
construct, and successfully targeted ES cells were identified by Southern blot 
analysis.  Correctly targeted clones were then transfected with recombinant Cre 
and screened for removal of the neomycin cassette to obtain the Tnfaip3 “floxed” 
allele.  Blastocyst injections of targeted ES cells were performed by the UCSF 
Transgenic Core. Chimeras were bred to albino C57BL/6J mice and non-albino 
progeny were screened for the presence of the floxed allele (Tnfaip3fl/+).  Mice 
bearing the targeted allele in the germline were interbred with CD19-Cre mice on 
the C57BL/6 background (B6.129P2(C)-CD19tm1(cre)Cgn/J) (Rickert et al, 1997).  
Tnfaip3fl/fl or Tnfaip3fl/+ mice homozygous for CD19-Cre were bred with Tnfaip3fl/fl 
or Tnfaip3fl/+ mice without the CD19-Cre allele to generate experimental mice of 
various A20 genotypes (Tnfaip3+/+, Tnfaip3fl/+ and Tnfaip3fl/fl) that have one copy of 
Cre and are heterozygous for CD19.   Genotypes were initially confirmed by 
Southern blot analysis and subsequently identified by PCR using the following 
primers:  5ʼ-AACTTTACAGTCCCCAGCAATGG-3ʼ (sense); and 5ʼ –
GAGGAGGTTGGAAGACATAGAATCG-3ʼ (antisense). 
 
 
Cell preparation and analyses. 
 
Single cell suspensions were prepared and incubated with the designated 
conjugated antibodies (all from BD Biosciences, except anti-CD5 and anti-CD93 
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(AA4.1), eBioscience), and live cells (DAPI-) were analyzed by flow cytometry 
(LSRII, BD Biosciences) using FlowJo software (Tree Star Inc.).  BMDMs were 
prepared as previously described (Boone et al., 2004). For in vitro assays, B-cells 
were isolated by negative depletion with TCRβ, Mac-1, NK1.1 and Ter119 
biotinylated antibodies (BD Biosciences) bound to streptavidin coated magnetic 
beads (M-280 Dynabeads, Invitrogen).  Cells were stimulated with anti-CD40 
(HM40-3, BD Biosciences) at 1 μg/ml, anti-μ chain (Jackson Immunoresearch) at 
2 μg/ml, IL-4 (Peprotech) at 10 ng/ml and LPS (Sigma) at 1μg/ml.  For in vitro 
deletion of Tnfaip3 exon 2 from GT-Rosa Cre B cells, cells were treated with 4-
OH-T (2.5 nM) for the first 12 hours of stimulation.  For NF-kB inhibition, control 
peptide or NBD Peptide (Calbiochem) were added at 0.5 μM one hour prior to 
stimulation with agonist anti-CD40 antibody. 
 
 
Mouse immunizations 
 
For in vivo antigen responses, 6-8 week old mice were injected intraperitoneally 
(ip) and bled on the indicated days.  Mice were injected with 50 μg NP-KLH 
(Biosearch Technologies) mixed 1:1 with Imject Alum (Thermo Scientific).  For 
CpG treatment, 8 week old mice were injected ip, every other day for 2 weeks, 
with 40 μg CpG ODN 2395 (tcgtcgttttcggcgcgcgccg) with phosphorothioate bases 
(Invitrogen).  Serum was collected before treatment, and 6 weeks post-treatment.  
All animal experiments were approved by the Institutional Animal Care and Use 
Committee at the University of California, San Francisco. 
 
 
Immunoglobulin and AFC determination 
 
Serum and supernatant immunoglobulin levels (total Ig, IgM, IgG1, IgG2c, IgG2b, 
IgG3 and IgA) were determined by isotype specific ELISA (Southern 
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Biotechnology, Birmingham, Alabama).  NP (4-Hydroxy-3-nitrophenylacetyl) -
specific antibody titers were determined by ELISA with plates coated with NP23-
BSA (Biosearch Technologies).  dsDNA-specific antibody titers were determined 
by ELISA with plates coated with Hind III (New England Biolabs) digested pUC19 
in 0.1M Tris, over-night at room temperature.  Cytokines levels were measured by 
ELISA as recommended by the manufacturer (BD Biosciences).  Elispot was 
performed by incubating enriched B cells on plates coated with dsDNA as above.  
After overnight incubation, plates were washed and incubated with alkaline 
phosphatase (AP) conjugated anti-IgM (Southern Biotech), and subsequently 
developed with BCIP substrate (Sigma) dissolved into alkaline phosphatase buffer 
(0.1M Tris, 0.1 M NaCl, 5 mM MgCl2) and 0.6 % LMP Agarose (Sigma).    
 
Autoantigen arrays were printed and processed as previously described. Arrays 
were probed with goat antibody specific for mouse Ig (Jackson Immunoresearch).   
Detailed protocols and lists of antigens have been published and are available 
online at http://utzlab.stanford.edu/protocols (Robinson et al., 2002).  Significance 
Analysis of Microarrays (SAM) was applied to the data to identify antigens with 
statistically significant differences in array reactivity between mutant and wild type 
mice (Tusher et al., 2001).   
 
 
Histology and immunohistochemistry 
 
Kidneys and spleens were fixed in 10% formalin.  Sections and H&E stain were 
performed by the UCSF VAMC Pathology Core.  For immunohistochemistry, 
kidneys were embedded in Tissue-Tek OCTTM compound and snap frozen in 
Methyl-butane with dry ice.  Tissue sections were then stained with IgM-FITC or 
IgG-FITC (Jackson Immunoresearch), IgG2c-FITC or IgG2b-FITC (Bethyl 
Laborotories Inc.). 
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Cell signaling assays 
 
Enriched B cells were stimulated as indicated in the figures, lysed in 0.1% NP-40 
(Calbiochem) lysis buffer, and nuclei spun down to yield cytoplasmic lysates.  
Lysates were cleared by centrifugation at 14,000 g for 20 min at 4 ° C, 
supernatants were removed, heated in Laemmli buffer and run on SDS-PAGE 
(Novex System, Invitrogen).  Immunobots were probed for A20 (Boone et al, 
2004), actin (JLA20, Calbiochem), phospho-IκBα, IκBα, phospho-Erk, Erk, 
phospho-NF-kB2 p100 and NF-kB2 p100/p52 (Cell Signaling), Bcl-x (Transduction 
Biotechnologies). 
 
 
Fas-induced cell death assay 
 
Fas-induced cell death assays were performed as described (Watanabe et al, 
1995; Wang et al., 1996).  Briefly, enriched B-cells were plated with agonist anti-
CD40 (1 μg/ml) for 60 hours.  Agonist anti-CD95 (Fas) was added to the cultures 
at the indicated doses for the last 12 hours.  Cells were harvested and stained for 
flow cytometry with Annexin-V (BD Biosciences) and DAPI. 
 
 
Real-time PCR assays 
 
For quantitation of genomic A20 exon 2, DNA was prepared using DNeasy Kit 
(Qiagen), after which qPCR was performed using SYBR Green (Qiagen).  Primers 
for exon 2 of A20 were the following: 5ʼ-CTGACCTGGTCCTGAGGAAG-3ʼ 
(sense); and 5ʼ-GCAAAGTCCTGTTTCCACAA-3ʼ (anti-sense).  This qPCR assay 
was shown to detect less than 1% of exon 2 DNA in titrated mixtures of Tnfaip3-/- 
and Tnfaip3+/+ cells (data not shown).   For quantitation of Bcl-x mRNA 
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expression, mRNA was prepared using RNeasy Kit (Qiagen) and cDNA was 
obtained with Quantitect Reverse Transcription Kit (Qiagen).  Primers for Bcl-x 
cDNA were the following: 5ʼ-GCAGACCCAGTAAGTGAGCA-3ʼ (sense) and 5ʼ-
AGAAAGTCGACCACCAGCTC-3ʼ (antisense).  In both types of assays, β-actin 
primers used as a reference were: 5ʼ- AAGTGTGACGTTGACATCCGTAA -3ʼ 
(sense) and 5ʼ- TGCCTGGGTACATGGTGG TA -3ʼ (antisense).  Assays were 
performed using an ABI 7300 real-time PCR machine (Applied Biosystems). 
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CHAPTER 4 
 
 
 
 
Final Discussion 
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 This thesis work covered two general but distinctly different aspects of 
A20ʼs function in the immune system. While the first part focused on innate 
immune responses, the second turned the scope of our attention on A20ʼs roles in 
adaptive immunity. In the end, just like both sides of the immune system are 
fundamental, these two stories might have complemented each other to build the 
route of my learning journey and hopefully still open doors that will lay the 
foundation for future research. 
 
 
 
 In chapter 2 of this work, we have shown that MyD88 deficiency largely 
reverses the A20-/- phenotype, demonstrating that MyD88-dependent signals need 
to be constantly regulated by A20 under homeostatic conditions, or otherwise 
cause systemic inflammation. Moreover, these MyD88-dependent signals appear 
to be initiated by gut commensals, as treatment with broad-spectrum antibiotics 
can also decrease spontaneous inflammation driven by A20 deficient cells. A20-/- 
hematopoietic cells seem to recognize microbes in the intestine and be sufficient 
to set off generalized inflammation. We have also demonstrated that A20 
terminates MyD88-independent, TRIF mediated TLR responses. Nevertheless, 
A20 seems to specifically regulate NF-κB signals rather than IRF signals 
downstream of TRIF. This suggests that rather than having an indiscriminate 
inhibitory role, A20 may have preferences for certain targets, namely those 
upstream of NF-κB. 
 
 Very recently, a conditional allele of A20 was used in conjunction with Villin-
Cre to obtain specific deletion of A20 in IECs (intestinal epithelial cells) (Vereecke 
et al., 2010). In contrast with our findings with hematopoietic cells, these mice do 
not develop any sort of spontaneous inflammation, even though they are more 
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sensitive to experimentally induced colitis than controls. Additionally, MyD88 
deficiency in these mice renders them more sensitive to induced colitis, rather 
than being protective. In contrast, TNF deficiency is protective, and these signals 
in IECs seem to be the most deleterious in the absence of A20. 
 
 These diverging results highlight how A20 can have cell type specific 
regulatory functions. Furthermore, these findings are consistent with previous 
reports that TLR stimulation in the intestinal epithelia is required for gut 
homeostasis (Rakoffnahoum et al., 2004). TLR stimulation in the intestinal 
epithelia is mostly beneficial, and IECs might be less sensitive to increased TLR 
signals. On the other hand, exaggerated TLR responses in immune cells that 
might survey the intestinal basal layer are more proinflammatory and need to be 
constantly terminated by A20. Cytokines such as TNF, which is produced by these 
cells, can then in turn be harmful to IECs. 
 
 Generation of lineage specific deletions of A20 will certainly provide 
additional insights into such specificities. In particular, generation of DC and 
macrophage lineage specific deletions of A20 can further confirm whether TLR 
signals in these cells alone are indeed responsible for driving systemic 
inflammation in the absence of A20. That being the case, it reinforces the role of 
A20 in terminating innate immune signals under homeostatic conditions. 
 
 
 
 In chapter 3 of this work, we have shown that A20 regulates B cell functions 
and homeostasis. A20 terminates BCR, CD40 and TLR induced responses in B 
cells. Mice with absent or hypomorphic A20 expression in B cells develop 
spontaneous autoimmunity. A20 deficient and hypomorphic B cells have 
increased survival to PCD (programmed cell death) and this might be a 
mechanism by which autoreactive cells escape selection in the case of aberrant 
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function or expression of A20. 
 
 We have identified additional pathways that are regulated by A20. Future 
studies might use B cells to define novel targets and mechanisms of this enzyme. 
Particularly, prolonged NF-κB signals downstream of CD40 could owe to 
prolonged TRAF2 ubiquitylation downstream of this receptor. In fact, TRAF2 has 
already been reported to interact with A20 in other contexts (Shembade et al., 
2010). Finally, just as A20 interacting proteins have been found to function in 
previously known A20 regulated pathways, it will be interesting to look at their 
roles in B cell signaling.  
 
 B cells integrate stimuli from various receptors in order to provide an 
appropriate outcome. A20 deficient B cells are hyperresponsive to most of these 
stimuli in vitro, and these defects probably account for failure at several levels of B 
cell function in vivo. Interestingly, selection seems to be particularly affected, 
whereas antigen-specific responses are mostly normal. Likewise, while B cell 
mediated autoimmunity and increased GC B cell numbers were observed with 
both absent or hypomorphic expression of A20, B cell hyperactivation is only 
obvious with total A20 absence. Differences probably stem from complex 
combinations of B cell intrinsic and extrinsic factors, like different NF-κB intensities 
and B – T cell interactions, respectively. While it is hard to predict all the resulting 
outcomes, perhaps mathematically modeling some of these variables could shine 
new light into these problems.  
 
 Meanwhile, it might be useful to explore the role of B – T cell interactions, 
which occur both at the T cell / B cell border of the follicle and later in the GCs. As 
reported in B cell specific deletion of Fas (Hao et al., 2008), we have observed 
that altered B cell function can drive T cell expansion, and each one of these cell 
subsets might feed into each other to further disrupt homeostasis. From this 
perspective, mice double deficient for A20 in B and T cells might be of particular 
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interest to explore such dynamics. 
 
 We have found that A20 restricts B cell survival to Fas mediated PCD upon 
CD40 stimulation and this might explain defective negative selection in GCs in the 
face of A20 deficiency. Nonetheless, this does not exclude additional points of 
escape of autoreactive cells in the absence of A20. In fact, it is likely that there is 
also impaired negative selection in the bone marrow, given the abundance of IgM 
(non-switched) autoantibodies. In this context, it will be of special interest to test 
different types of cell death in B cells isolated from both spleen and bone marrow. 
Furthermore, examining Tnfaip3fl mice for the additional mechanisms of B cell 
selection, receptor editing and anergy induction, can also be elucidating. 
 
 Finally, although we have not observed obvious signs of B cell lymphomas 
in mice aged up to one year old, given the many associations between A20 and B 
cell lymphomas it might be worth further exploration into the signs of malignancy 
in Tnfaip3fl/fl mice. Specifically, increased survival at GCs can result in increased 
AID (activation-induced cytidine deaminase) expression and result in increased 
oncogene translocations, related with malignancy (Robbiani et al., 2008; Takizawa 
et al., 2008). Because GC formation and retention is intimately tied to CD4 T cells, 
it remains possible that A20 deficiency in T cells as well as B cells may also lead 
to altered T cell help and ultimately the survival of malignant cells. 
 
 
 
 In conclusion, we have unveiled several novel functions of A20 that 
significantly contribute to the appropriate functioning of the immune system, innate 
and adaptive. Absent or altered expression of A20 in different cell types results in 
a number of defects, highlighting the increasingly accepted position of A20 as a 
central regulator of immune function. 
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 Importantly, our observations emphasize how immune tolerance can be 
broken through different immune cell types, by manipulating a single gene. 
Complete ablation of expression in all immune lineages resulted in exaggerated 
inflammation in a broad, pathogen or danger associated signal. Concurrently, 
reduced expression in B lymphocytes alone affected the fine workings of self-non-
self discrimination of acquired immunity. 
 In Chapter 1 I discussed how the operation of the entire immune system 
results from the incorporation of signals from different cells, belonging to both the 
innate and the adaptive immune systems, but also to the tissues with which 
immune cells interact. Each immune cell, in turn, integrates those different 
external inputs into the cell. While we continue to discover how A20 functions at 
the intracellular level of many cells, it is equally evident that these intracellular 
processes can result in system wide consequences. And even if some levels 
seem to be more of a tipping point than others, it seems evident that there have to 
be checking points at all of them, and that maintenance of immune homeostasis 
and tolerance depends on the efficient intracellular control by molecules as A20. 
 
 For all this, I think there are many reasons to predict that additional lineage 
specific deletions of A20 will continue to reveal exciting and hitherto unknown 
roles for A20 in immunity and beyond. 
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APPENDIX  
 
 
 
 
Unpublished preliminary data 
and future directions 
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BAFF mediated survival and death by neglect of A20 deficient B cells 
 
 In order to assess A20ʼs role in restricting B cell survival in additional 
contexts, we isolated B cells from spleen and bone marrow and tested them for 
cell death in further conditions. Specifically, BAFF is known to promote B cell 
survival and be determinant during B cell development and selection (Sen, 2006). 
Additionally, we observed that Tnfaip3fl/fl B cells have higher basal levels of p100, 
enabling these cells to hyperrespond to BAFF signals, which activate this non-
canonical NF-κB pathway. 
 
 We have isolated B cells from bone marrow and spleens from Tnfaip3+/+, fl/+ 
and fl/fl CD19-Cre mice and cultured them with increasing doses of BAFF at 
different time points. In this primary data (Figure 2.1), we found no consistent 
differences between genotypes in BAFF mediated survival. On the other hand, we 
tested B cell survival in the absence of any stimulation in culture (“death by 
neglect”) and found that there was a consistent difference between genotypes, 
with decreasing doses of A20 corresponding to increased survival to lack of 
stimulation. 
 
 These preliminary observations suggest that A20 might restrict B cell 
survival in particular contexts, rather than indiscriminately. A20 does not seem to 
limit BAFF mediate B cell survival, whereas its deficiency or lower expression 
result in increased survival to lack of stimulation. It still remains to be tested 
whether BCR induced death is affected by A20, in the absence or presence of 
different doses of counteracting survival cytokines IL-4 and BAFF. These results 
should contribute to further tease out the mechanisms by which A20 can regulate 
B cell survival and eventually negative selection. 
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Figure 2.1 – BAFF mediated B cell survival. Data is representative of two 
independent experiments.  
 
 
Kappa and lambda chains expression in Tnfaip3fl mice 
 
 So as to assess other mechanisms of negative selection that could be 
affected by A20, we planned on measuring receptor editing in Tnfaip3fl CD19-Cre 
mice. Induction of receptor editing might also depend on NF-κB activation levels 
during B cell development and differentiation (Derudder et al., 2009). We have not 
looked directly at receptor editing, but we have measured kappa (κ) and lambda 
(λ) chains in the serum of Tnfaip3fl CD19-Cre mice, as well as the relative 
abundances of κ and λ positive B cells by flow cytometry. In serum, we have 
found progressively increased levels of both chains with lower or absent 
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expression of A20, probably due to corresponding increased levels of total Ig. 
There was a bias towards more Igλ in the absence of A20, which curiously was 
more apparent in anti-dsDNA autoreactive Ig (Figure 2.2). Flow cytometry analysis 
of spleen and bone marrow B cells showed no significant alterations in the 
percentages of each κ and λ individual populations between the 3 genotypes. 
However, again there seems to be a bias towards higher overall λ expression, 
with an increase in double positive cells corresponding to decreasing A20 (Figure 
2.3) 
 
 Since receptor editing promotes replacement of Igκ light chains by Igλ 
ones, these observations suggest that there is no defect in receptor editing. On 
the contrary, there could be increased induction of expression of λ chains that 
could be a consequence of increased NF-κB in the absence of A20. Definitive 
conclusions would require direct assessment of receptor editing. 
 
 
Figure 2.2 – Elisas of serum from the indicated mice genotypes at 3 months of 
age. (Top Graphs) Total Igκ and Igλ and (Bottom Graphs) anti-dsDNA specific Igκ 
and Igλ. 
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Figure 2.3 – Flow cytometry analysis of κ and λ B cell populations in spleen and 
bone marrow of Tnfaip3fl CD19-Cre mice of the indicated genotypes. All samples 
were gated on CD19+ cells and (A) IgM+ (B) IgG+. Data are representative of 3 
sets of mice. 
 
 
Decreased high affinity Ig in T-dependent responses in the absence of A20 
 
 We asked whether affinity maturation was altered in the absence of A20. 
Even though we have not made most direct evaluations, we measured antibodies 
in T-dependent antigen specific responses by NP3 versus NP23 Elisas, which can 
give a good indication of the higher versus lower affinity nature, respectively, of 
the antibodies produced. Strikingly, even though Tnfaip3fl/fl CD19-Cre mice make 
some more IgM, IgG antibodies seems to be of considerably lower affinity. This 
might be explained by the increased survival of A20 deficient B cells. While in 
wild-type mice lower affinity B cells do not survive due to weaker stimulation, 
Tnfaip3fl/fl cells might live as a consequence of stronger signals in the absence of 
A20. Overall, this decreases the affinity of the Ig pool produced. 
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Figure 2.4 – Elisa plates coated with NP3 (top) versus NP23-BSA (bottom) were 
used to analyze the sera from mice of the indicated genotypes, immunized with 
NP-KLH, at the indicated days post-immunization. Means ± SEM of five mice per 
genotype. 
 
 
Disrupted spleen architecture in Tnfaip3fl/fl CD19-Cre mice 
 
 We have examined the structure of spleens of Tnfaip3fl CD19-Cre mice. 6 
month-old mice have a marked loss of splenic architecture observable by H&E 
staining (Figure 2.5 top panel). We performed immunohistochemistry stains to 
look at cell populations in these spleens. In Figure 2.5, bottom panel, T cells are in 
green, B cells in blue, and Marginal Zone (MZ) in red. Tnfaip3fl/fl mice and to a 
lesser extent Tnfaip3fl/+ show increased numbers of T cells outside the central T 
cell area normally observable in Tnfaip3+/+ mice. 
 
 Some of the spleens with noticeable loss of splenic architecture had the 
appearance of pre-malignant lesions. Such observation could be a good pointer 
that is worth further aging these mice and pursue other signs of malignancy that 
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might not be grossly obvious. On another note, the observation of T cells moving 
to the B cell zone in Tnfaip3flfl spleens reinforces the notion that B cells are 
influencing T cell behavior, driving its expansion and perhaps its positioning in 
follicles. Further analysis of this kind, in spleens and lymph nodes, might also 
reveal interesting. From the same perspective, analysis of Tnfaip3fl CD19-Cre 
CD4-Cre double mice with A20 double in B an T cells might teach us more about 
these interactions. 
 
 
 
 
Figure 2.5 – Spleens from 6 month old mice of the indicated genotypes. Top 
panel H&E staining, 100X magnification. Bottom panel, immunohistochemistry in 
frozen sections, 500x magnification shows part of one follicle. Green Thy1.1, Blue 
B220, Red MadCam. Data are representative of 5 mice per genotype. 
 
 
B – T cell interactions in Tnfaip3fl CD19-Cre CD4-Cre double deleted mice 
 
 Tnfaip3fl/fl CD19-Cre B cells alone drive expansion of T cells, but no 
consistent T cell activation was ever observed in these mice. In light of the role of 
B –T cell interactions for lymphoid homeostasis and negative selection of B cells, 
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we have crossed Tnfaip3fl CD19-Cre mice with CD4-Cre mice to obtain double B 
and T cell A20 deficient mice. T cell lineage specific deletion of A20 results in 
spontaneous T cell activation, but T cell numbers decrease, likely due to activation 
induced cell death (S. Oshima, unpublished data). We thus asked whether 
cooperation between hyperresponsive B and T cells could result in exacerbation 
of the two individual phenotypes. 
 
 Surprisingly, B cell percentages are markedly reduced in double Cre 
Tnfaip3fl/fl mice, at the expense of an increase in T cell percentages (Figure 2.6 A). 
As total cellularity is not lower but even increased in the absence of A20 (data not 
shown), the net result is moderately lower total B cell numbers and strikingly 
expanded T cell numbers. While no obvious differences were found in myeloid 
populations, GC B cell percentages are dramatically increased, similarly to what is 
observed in Tnfaip3fl single CD19-Cre mice (Figure 2.6 A, B). So in spite of lower 
B cell numbers, there are still significantly higher GC B cell numbers. As in single 
CD19-Cre mice, there are increased total levels of Fas expressed in B cells in the 
absence of A20 (Figure 2.6 C). Additionally, we have measure ICOS-L (which 
binds ICOS on T cells) on the surface of B cells, and found similarly increased 
levels of ICOS-L in the absence of A20 (Figure 2.6 C). 
 
 CD4+ T follicular cells (TFH) are known for interacting with B cells by 
moving to the B cell zone due to upregulation of CXCR5. These cells also express 
higher ICOS levels than non-follicular T cells. Tnfaip3fl/fl double Cre CD4+ T cells 
did not express higher CXCR5, suggesting T cells might migrate to the B cell zone 
(Figure 2.5) independently of CXCR5 upregulation. Conversely, ICOS levels were 
elevated in the absence of A20, which along with higher ICOSL levels on B cells 
suggests crosstalk mediated by this receptor. 
 
 Finally, we measured T-cell activation in CD4 and CD8 T cells in spleens 
and lymph nodes of the double CD19 / CD-4 Cre mice. Remarkably, we found a 
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very significant increase in T cell activation, (2-4 fold) in both Tnfaip3fl/fl and 
Tnfaip3fl/+ mice. 
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Figure 2.6 – Flow cytometry analysis of spleens and lymph nodes from Tnfaip3+/+, 
fl/+ and fl/fl CD19-Cre+/- CD4-Cre+ 4 month-old mice. A) Lineage stains for T-cells 
(TCRβ+), B-cells (B220+), Myeloid cells (Mac1+) and NK cells (NK1.1+). B) Stains 
for GC B cells (GL7Hi, CD95Hi) gated on B220+. Histograms showing C) CD95 / 
Fas and ICOSL expression on B220+ gated cells and D) CXCR5 and ICOS 
expression in CD4+ gated cells. E) Stains for CD62L and CD44 in CD4+ or CD8+ 
gated cells as indicated. Activated T cells are CD44Hi CD62LLo and naïve T cells 
are CD62LHi CD44Lo. Data are representative of 3 mice per genotype 
 
 
 This data suggests that simultaneous A20 absent or hypomorphic 
expression in B an T cells may perhaps reveal additional details on T – B cell 
interactions, and how A20 contributes to regulate each arm of the adaptive 
immunity. In this context, it will be worth testing whether activated T cells are 
killing B cells through expression of Fas-L. Additionally, it is possible that activated 
A20 deficient B cells give survival signals to activated A20 deficient T cells that 
otherwise could die. Moreover, measuring autoantibodies and its deposits in these 
mice possibly will clarify whether this setting exacerbates autoimmunity, or on the 
contrary, myeloid cells or others, in the absence of A20, contribute to disease 
progression. Finally, investigating signs of malignancy in these mice can also 
clarify whether this could be a lymphoma prone setting. 
 
 
 
 In conclusion, although all these results are preliminary, they stress the 
many possibilities of carrying on exploring some of the novel functions of A20 first 
described in this thesis work. 
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